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HIV/AIDS AND BLOOD DONATION POLICIES:
A COMPARATIVE STUDY OF PUBLIC
HEALTH POLICIES AND INDIVIDUAL
 RIGHTS NORMS*
I.  INTRODUCTION
This paper presents a comparative study of blood donation poli-
cies in force in the United States, Canada, Denmark, Australia,
Uganda, and Singapore which demonstrate the balance between ef-
fective health policy and individual rights norms.  This study exam-
ines national public health policy formulation and implementation,
specifically focusing on how the paradigms of law and epidemiology
are reconciled to create effective public health policies.  This analysis
highlights policy differences between states like the United States and
Canada, where the national governments have limited power and
confer comparatively strong individual rights guarantees, and those
like Denmark and Singapore, which assume a “duty ‘to do right for
the people’” and in which, in certain circumstances, collective rights
subordinate individual rights.1
Especially since the diagnosis and identification of human immu-
nodeficiency virus (HIV) and its end-stage disease acquired immune
deficiency syndrome (AIDS), national governments, often in concert
with non-governmental organizations, have sought to guarantee safe
blood supplies.2  Governments are compelled by national and interna-
Copyright © 2001 by Francine A. Hochberg
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1. Thio Li-ann, The Constitutional Framework of Powers, in THE SINGAPORE LEGAL
SYSTEM 67, 73 (Kevin Y.L. Tan ed., 2d ed. 1999).
2. See Timothy S. Rothermel, AIDS: Its Impact on Development Programmes, in THE
GLOBAL IMPACT OF AIDS 163 (Alan F. Fleming et al. eds., 1988); see also GLOBAL BLOOD
SAFETY INITIATIVE, CONSENSUS STATEMENT ON ACCELERATED STRATEGIES TO REDUCE
THE RISK OF TRANSMISSION OF HIV BY BLOOD TRANSFUSION WHO/GPA/INF/89.13,
WHO/LAB/89.6 (Mar. 20–22, 1989) [hereinafter GBSI]; WORLD HEALTH ORGANIZATION,
GUIDELINES FOR QUALITY ASSURANCE PROGRAMMES FOR BLOOD TRANSFUSION SERVICES
(1993).  For a discussion of the blood donation policies enacted to reduce blood transfusion re-
HOCHBERG_FMT.DOC 01/24/02  9:25 AM
232 DUKE JOURNAL OF COMPARATIVE & INTERNATIONAL LAW [Vol 12:231
tional interests to guarantee safe blood supplies.3  Many critics, how-
ever, view the terms of blood donation and screening policies in the
United States and other countries as unreasonably burdening individ-
ual rights, though these policies were conceived to comply with inter-
national recommendations, like those promulgated by the World
Health Organization (WHO).4
This paper takes as its point of departure concerns that the ex-
clusionary criteria for blood donation used in the countries studied
may be viewed as discriminatory.  The prohibition of blood donations
by groups considered at high risk for HIV, including men who have
sexual relations with other men (MSM), is an example of a potentially
problematic exclusionary criterion.  This paper discusses whether
these criteria, including the prohibition on blood donations by MSM,
may be regarded as justifiable to prevent transfusion-related trans-
mission of HIV and other blood-borne pathogens, and to protect the
public health and the rights of individuals receiving blood transfu-
sions.  Ultimately this paper concludes that the policy determination
that exclusionary criteria are justifiable depends upon the reconcilia-
tion of the differing concepts of right and risk in law and epidemio-
logy.  In the context of blood donation policies in the countries dis-
cussed, exclusionary criteria that effectively target individuals in high
risk groups and prevent them from donating blood are justifiable be-
cause they reduce the risk of contaminated blood entering the blood
supply.
lated transmission of HIV in the United States, Canada, Denmark, Singapore, Uganda, and
Australia, see infra section III.A–F.
3. The specific sources of international law and relevant international and multi-national
policies pertaining to this issue are beyond the scope of this paper.  The World Health Organi-
zation (WHO), the World Health Organization’s Global Programme on AIDS, the Global
Blood Safety Initiative (GBSI), the United Nations Development Programme (UNDP), and the
League of Red Cross and Red Crescent Societies have worked extensively on this issue and
have promulgated several nonbinding consensus statements and models for reducing transmis-
sion of HIV by blood transfusion.  See generally GBSI, supra note 2.  These statements and rec-
ommendations do not constitute binding international law.  DAVID P. FIDLER, INTERNATIONAL
LAW AND INFECTIOUS DISEASES 58 (1999).  The only “international health agreement on
communicable diseases [that is] binding on [WHO] Member States” is the International Health
Regulations.  Id.  Sexually Transmitted Diseases—communicable diseases—like AIDS/HIV are
not included in the IHR and may not be included in the revised regulations set to be released in
2002.  Michelle Forrest, Note, Using the Power of the World Health Organization: The Interna-
tional Health Regulations and the Future of International Health Law, 33 COLUM. J.L. & SOC.
PROBS. 153, 172 (2000).
4. FDA Panel Rejects Bid to Ease Ban on Blood Donations by Gays, N.Y. TIMES, Sept. 15,
2000, at A29 [hereinafter FDA Panel]; Marjolein Harvey, Gay Rights Pitted Against Patient
Rights in Blood Bank Debacle (Mar. 28, 2000) (on file with the Duke Journal of Comparative
and International Law).
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Because public health interventions, such as those described in
the six case studies, are concerned with maximizing community
health, individual interests or rights often are not the primary focus of
public health policy makers.  Public health analysis, specifically that
undertaken by epidemiologists, is concerned predominately with the
health of populations or communities.  The individual is considered as
a part of the community, not as an individual per se.  A public health
policy thus might appear to be overbroad, or an exclusion unjustifi-
able, when considered from a legal perspective concerned with pro-
tecting individual rights.  However, such apparent overbreadth may
be, and often is, acceptable and even necessary in cases in which the
public health policy is proven effective.  In a legal analysis, even
broad exclusions may be viewed as sufficiently narrowly tailored
when the exclusion is strictly drawn epidemiologically.  For example,
where HIV seroprevalence is high in a given population—as it is
among MSM or injection drug users in several of the countries stud-
ied—the prohibition of blood donations by individuals within those
populations is considered an acceptable and effective measure to pre-
vent transfusion-related transmission of HIV.5  Exclusionary criteria
thus are justifiable so long as they effectively reduce the risk of
transmissibility of HIV or other blood-borne pathogens, advancing
the goal of the public health measure.
This paper arrives at the above conclusion after presenting a
background of HIV/AIDS, the blood supply, and donor self-
exclusion.  The six comparative studies of national public health poli-
cies illustrate how states have sought to balance the apparently com-
peting interests of protecting the blood supply and the health of do-
nees with the rights and interests of donors.  This paper ultimately
considers the extent to which limitations imposed by national public
health policies, specifically blood donation policies, may be regarded
as necessary and justifiable limitations on individual rights to promote
public health.
II.  HIV/AIDS AND THE BLOOD SUPPLY
Since their emergence and identification, HIV and its end-stage
disease AIDS have had a profound and devastating impact not only
on human health and population, but also on human society, eco-
5. See discussion infra section III.A–F.
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nomics, and politics.6  HIV/AIDS is responsible for more deaths glob-
ally than is any other virus.7  Since the outset of the epidemic in the
late 1970s and early 1980s, 21.8 million people have died from
HIV/AIDS and related causes; as of December 2000, 36.1 million
people were living with the disease.8  These figures are more than
50% higher than those projected in 1991 by the WHO’s Global Pro-
gramme on AIDS.9
Most of the prevention strategies recommended for reducing
HIV transmission in both developed and developing countries have
focused on behavior-change interventions.10  These primarily aim to
reduce the sexual transmission of HIV.  Such a focus is well-founded,
as HIV is transmitted primarily through sexual activity: heterosexual
transmission accounts for up to 80% of adult HIV infections in sub-
Saharan Africa.11  In the United States, sexual transmission, both ho-
mosexual and heterosexual, accounted for 57% of AIDS cases re-
ported through 2000.12  HIV, however, is also “acquired through peri-
natal and parenteral transmission.”13  Perinatal transmission of HIV
(women transmitting the virus to their children either in pregnancy or
in childbirth) has been estimated to cause up to 15% to 20% of HIV
6. See LAWRENCE O. GOSTIN & ZITA LAZZARINI, HUMAN RIGHTS AND PUBLIC
HEALTH IN THE AIDS PANDEMIC xiii (1997); cf. T. BARNETT & P. BLAIKIE, AIDS IN AFRICA:
ITS PRESENT AND FUTURE IMPACT 102 (1992) (Researching 129 households in Rakai, Uganda,
the authors find that “AIDS had not yet drawn adaptive responses in production and consump-
tion [that differ significantly from] the many other adaptations households make . . . in response
to other rapid processes of socioeconomic change.  However, [the authors] believe that in cer-
tain localized areas, AIDS is beginning to be the major determinant of socioeconomic
change.”).
7. Mortality rates due to HIV/AIDS have far surpassed those due to both malaria and
tuberculosis.  STEPHANIE WASSERMAN, NATIONAL CONFERENCE OF STATE LEGISLATURES,
HIV/AIDS FACTS TO CONSIDER: 1999 3 (1999).
8. UNAIDS, AIDS EPIDEMIC UPDATE: DECEMBER 2000, at 3, UNAIDS/00.44E-
WHO/CDS/CSR/EDC 2000.9 (English Original, Dec. 2000), available at http://www.unaids.org/
epidemic_update/report_dec00/index_dec.html (last visited Oct. 28, 2001) [hereinafter AIDS
Epidemic Update].
9. Id. at 4.
10. See NATIONAL RESEARCH COUNCIL, PREVENTING AND MITIGATING AIDS IN SUB-
SAHARAN AFRICA 157–93 (1996).
11. Id. at 83 (citing P. Piot et al., AIDS: An International Perspective, 239 SCIENCE 573–79
(1988)).
12. Centers for Disease Control, HIV/AIDS—United States, 1981–2000, 50 MORBIDITY
AND MORTALITY WKLY. REP. 430, 430 (2001).
13. NATIONAL RESEARCH COUNCIL, supra note 10, at 83.
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infections.14  Parenteral transmission (transmission through blood
transfusion, injection, or scarification) has been found to account for
over 10% of all HIV infections in sub-Saharan Africa,15 and approxi-
mately 25% of cases of AIDS in the United States.16  The substantial
majority of cases of HIV caused by parenteral transmission in devel-
oping countries, especially those in sub-Saharan Africa, are caused by
transfusion-related transmission, as opposed to in developed coun-
tries, where the majority of cases caused by parenteral transmission
result from injection drug use.17
HIV is transmitted successfully through vaginal and anal inter-
course at a rate of between 0.1% and 1%.18  By comparison, the suc-
cess of HIV transmission is over 90% when infected blood is trans-
fused to a formerly uninfected person.19  Direct blood contact is one
of the most efficient, yet most preventable, forms of HIV transmis-
sion.20  In fact, an internationally recognized AIDS researcher asserts
that “the most successful single achievement in the prevention of HIV
infection has been the drastic reduction in transfusion-acquired infec-
tion resulting mainly from effective screening of donated blood.”21  In
developed countries, the rate of HIV infection resulting from blood
transfusions with contaminated blood is virtually zero;22 the blood
supplies in these countries are effectively free of HIV.23  In developing
countries, however, especially those in sub-Saharan Africa, the infec-
14. Id. at 94 (citing T.C. Quinn, et al. Special Considerations For Developing Nations, in
PEDIATRIC AIDS: THE CHALLENGE OF HIV INFECTION IN INFANTS, CHILDREN, AND
ADOLESCENTS 31–49 (P.A. Pizzo & C.M. Wilfert eds., 1994)).
15. Id. at 97; see also Eve M. Lackritz et al., Blood Transfusion Practices and Blood-
Banking Services in a Kenyan Hospital, 7 AIDS 995, 995 (1993).
16. Centers for Disease Control, supra note 12, at 430.
17. See Lackritz et al., supra note 15, at 995; see also Centers for Disease Control, supra
note 12, at 430.  The percentages presented describing the proportions of HIV infections attrib-
utable to the different transmission mechanisms do not add up to 100% because they are esti-
mates.  Statistical estimations vary according to the representative populations studied.
18. EUROPEAN COMMISSION, DEVELOPMENT: STUDIES AND RESEARCH, SAFE BLOOD IN
DEVELOPING COUNTRIES 17 (C. Gerard et al. eds., 1995) [hereinafter Gerard].
19. BARRY D. SCHOUB, AIDS AND HIV IN PERSPECTIVE: A GUIDE TO UNDERSTANDING
THE VIRUS AND ITS CONSEQUENCES 111, 114 (2d ed. 1999).
20. See id. at 110–11.
21. Id. at 114.
22. Gerard, supra note 18, at 17.
23. The blood supplies in developed countries such as Canada, Australia, Denmark, and
the United States have been free of HIV only since the mid- to late-1980s.  Prior to the imple-
mentation of effective screening programs there were significant numbers of transfusion-related
HIV infections.  See infra section II.A–D; see also Centers for Disease Control, supra note 12, at
433.
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tion rate resulting from blood transfusions is still significant, ap-
proximately 10%.24  Safe blood strategies therefore must be imple-
mented and enforced to reduce the rate of HIV transmission by blood
transfusions.
In addition to reducing the rate of HIV transmission, safe blood
supplies reduce the risk of transmission of other blood-borne patho-
gens.25  Safe blood supplies minimize the risk of transmitting “acute
microbial infections,”26 and generally increase public health: blood’s
therapeutic and life-saving uses range from transfusions to pharma-
ceutical products made from blood components.27
Various organizations, including the European Commission’s Di-
rectorate General for Development and the WHO/United Nation
Development Programme (UNDP) Global Blood Safety Initiative
(GBSI), have recommended strategies for maintaining a safe blood
supply.28  The GBSI recommendations state that blood should be ob-
tained from voluntary, non-remunerated donors from low risk popu-
lations.29  The recommendations also urge that donors be questioned
about HIV-associated symptoms and risk factors, and given the op-
portunity to exclude themselves from donation (self-exclude) confi-
dentially.30  The emphasis on confidentiality and on individual rights
24. See Centers for Disease Control, supra note 12.
25. Blood borne agents transmissible by blood transfusion include viruses, such as hepatitis
B (HBV) and C (HCV); human T-cell leukemia types one and two (HTLV-1, 2); bacteria, such
as syphilis (Treponema pallidum), brucellosis (Brucella abortus) which causes undulant fever,
and the spirochete that causes lyme disease (Borrelia burgdorferi); and parasites, such as those
that cause malaria, Chagas’ disease, and trypanosomiasis.  John A. J. Barbara, Transfusion-
Transmitted Infections: Epidemiology Relevant to Blood Safety, in 1 QUALITY ASSURANCE IN
TRANSFUSION MEDICINE 419, 423 (Gail Rock & M. J. Seghatchian eds., 1992).  There has been
extensive debate as to whether variant Creutzfeldt-Jakob disease (vCJD) is a blood borne dis-
ease.  See infra text accompanying note 123.
26. Barbara, supra note 25, at 420.
27. Ronald Bayer & Eric Feldman, Introduction: Understanding the Blood Feuds, in
BLOOD FEUDS: AIDS, BLOOD, AND THE POLITICS OF MEDICAL DISASTER 2 (Eric A. Feldman
& Ronald Bayer eds., 1999).
28. See supra note 3.
29. Gerard, supra note 18, at 42.
30. See INSTITUTE OF MEDICINE, HIV AND THE BLOOD SUPPLY: AN ANALYSIS OF CRISIS
DECISIONMAKING 128 (Lauren B. Leveton et al. eds., 1995).
A risk factor is a variable (demographic [e.g., age or gender], clinical [e.g., family history of
disease or behavior], or laboratory [e.g., biological or physiological characteristic—for example,
high cholesterol is considered a laboratory risk factor for heart disease]) associated with either
an increased or decreased risk of developing the disease.  In a prospective study, it is measured
at baseline from which people are followed forward until they develop the disease; the risk rela-
tionship is called the relative risk.  In a retrospective study, it is measured by questionnaire after
identifying who is a case and who is a control; the risk relationship is called the odds ratio (odds
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demonstrates the various organizations’ commitments to balance
public health strategies with human rights concerns.31
Even as blood-screening technologies improve and become in-
creasingly available and required by law in many countries including
South Africa,32 Canada,33 and the United States,34 obtaining blood do-
nations from low risk donors is nevertheless still important because
blood screening procedures are not 100% effective.35  More impor-
tantly, use of low risk donors minimizes the possibility of blood dona-
tion by infected individuals who are in the window period during
which HIV is “invisible to laboratory screening procedures.”36  The
of exposure in someone with the disease divided by the odds of exposure in someone without
the disease).  See generally JOHN M. LAST, A DICTIONARY OF EPIDEMIOLOGY (1988).
31. See GOSTIN & LAZZARINI, supra note 6, at 51–54.  The London Declaration on AIDS
prevention, endorsed by the World Health Assembly, emphasized “the need in AIDS preven-
tion programmes to protect human rights and human dignity.  Discrimination against, and stig-
matization of, HIV-infected people and people with AIDS and populations groups undermine
public health and must be avoided.”  Id.
32. Charles Ngwena, Legal Responses to AIDS: South Africa, in LEGAL RESPONSES TO
AIDS IN COMPARATIVE PERSPECTIVES 117, 121 (Stanislaw Frankowski ed., 1998); see also
STANDARDS FOR THE PRACTICE OF BLOOD TRANSFUSION IN SOUTH AFRICA (3rd ed. 1999);
Human Tissue Act 1983, 6 BSRSA 2000 (S. Afr.).
33. See infra section III.A.
34. See infra section III.B.
35. The ELISA (enzyme-linked immunosorbent assay) test to detect HIV antibodies in
blood is 99.7% effective, making it one of the most sensitive of all viral serological tests.
SCHOUB, supra note 19, at 115.  Rapid tests that can yield results in minutes, like the latex ag-
glutination test, are also widely used.  Both of these tests, however, can only confirm seroposi-
tivity when HIV antibodies are present in the patient’s serum (blood).  Id. at 130, 135.  On aver-
age, antibodies are not present in blood until twenty-five days after infection; thus the average
window period during which the ELISA and rapid tests are ineffective is twenty-five days.  Ai
Ee Ling et al., Failure of Routine HIV-1 Tests in a Case Involving Transmission With Presero-
conversion Blood Components During the Infectious Window Period, 284 JAMA 210, 210
(2000).  Theoretically, the p24 antigen detection ELISA test (looking for p24 antigen from the
core of the virus) should shorten the window period, as p24 antigen on average can be detected
“about 6 days before antibody tests become positive.”  Id. at 210–11.  Researchers, however,
have found that the test is too insensitive for widespread use.  SCHOUB, supra note 19, at 139,
153; see also INSTITUTE OF MEDICINE, supra note 30, at 78; JP AuBuchon et al., Cost-
effectiveness of Expanded Human Immunodeficiency Virus-testing Protocols For Donated
Blood, 37 TRANSFUSION 45–51 (1997) (“Although expanding the donor HIV screening protocol
with p24 antigen or RNA PCR testing will prevent rare cases of transfusion-associated HIV, the
cost-effectiveness of such an addition is predicted to be far below that of most medical interven-
tions.  Thus, HIV test protocol additions are unlikely to provide cost-effective improvements to
blood safety in the United States.” (citations omitted)); cf. Eve M. Lackritz, Prevention of HIV
Transmission By Blood Transfusion in the Developing World: Achievements and Continuing
Challenges, 12 AIDS S81 (Supp. A 1998) (“HIV-1 p24 antigen testing was implemented in the
USA in March 1996.  In the first 18 months of p24 antigen testing, an estimated 18 million blood
donations were tested at a cost of US$90 million to detect three antigen-positive, antibody-
negative donations.”).
36. SCHOUB, supra note 19, at 115.
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window period is the period of approximately six to eight weeks fol-
lowing infection.  During this time, individuals infected with HIV
have a large viral load but detectable antibodies are not yet present in
the infected individual’s blood.37
Because of the risks associated with blood donors donating in-
fected blood during the window period, thereby introducing HIV into
the blood supply, “[e]xclusion of blood donors with an increased risk
of HIV infection is considered an effective strategy to reduce the re-
sidual risk of HIV contamination [of the blood supply].”38  However,
as William McFarland, a noted epidemiologist, has written, the de-
termination of such criteria is difficult; thus, “[t]he search for HIV
risk factors to use as criteria for exclusion from blood donation has
been the subject of much recent transfusion-related research.”39  As
much current research shows, infected populations and risk factors
vary extensively from country to country and even within countries.40
In the United States, for example, the collection of blood from pris-
oners is prohibited because the incidence of HIV and other commu-
nicable diseases is higher among the prisoner population than among
comparable populations.41  Thus, in order for the exclusion of blood
donors to protect the blood supply effectively from viral contamina-
tion, the exclusionary criteria must be tailored to the specific epide-
miological situation of the given country and in fact exclude individu-
als who are at an increased risk for both prevalent and incident HIV.42
In developed countries, pre-donation screening to exclude high
risk individuals, also referred to as behavior risk-factor screening or
donor self-exclusion, used in combination with serological or biologi-
cal screening has been highly effective in reducing both the number of
37. See id.
38. William McFarland et al., Risk Factors for Prevalent and Incident HIV Infection in a
Cohort of Volunteer Blood Donors in Harare, Zimbabwe: Implications for Blood Safety, 11
AIDS S97, S98 (Supp. 1 1997); see also infra note 293.
39. Id.
40. See generally AIDS EPIDEMIC UPDATE, supra note 8.
41. Richard G. Cable, Conducting the Blood Donor Medical Interview, in 1 QUALITY
ASSURANCE IN TRANSFUSION MEDICINE 105, 108 (Gail Rock & M. J. Seghatchian eds., 1992).
42. See McFarland et al., supra note 38, at S98.  Incidence is a measure of the risk of devel-
oping the disease in the population.  Incidence is defined for epidemiological purposes as the
number of new cases of a disease that occur in a specific population at risk for developing the
disease in a given time period divided by the number of such persons.  People who have the dis-
ease at the beginning of that time interval are not at risk of becoming incident cases but do con-
tribute to the prevalence of the disease.  The prevalence is the number of cases of a disease di-
vided by the number of individuals in the population at a specific time point.  Prevalence is a
measure of the burden of disease in the population.  See generally LAST, supra note 30.
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blood donations from people who are HIV-positive at the time of do-
nation and the risk of infection by blood donated during the window
period.43  This high success rate is due to the fact that screening crite-
ria have been closely linked to epidemiological risk factors for an ex-
tended period of time.44  A minimal risk remains, however, as “blood
collected from asymptomatic donors in the window period often is
highly infectious and is considered the principle remaining reason
why disease still can be transmitted by screened units of blood.”45
In France, the risk of HIV transmission through blood transfu-
sion has been reduced by the use of pre-donation interviews in com-
bination with serological screening.  In French blood donation cen-
ters, donors are screened by interview rather than by a strict
questionnaire.  At the Foundation Nationale de Transfusion Sanguine
in Paris, France,
the doctors performing this interview are requested to ask ques-
tions regarding classical risk factors such as homosexuality, drug
addiction, contacts with at risk partners, history of transfusion,
rather than presenting donors with a rigid written questionnaire.
The quality of this interview is important: the physical conditions
and the questions asked must take into account the latest epidemi-
ological data on HIV infection in the country, in particular the risk
factors of HIV infection, in order to frame suitable questions for the
medical interview.46
In France, the United States, and other developed countries, the use
of pre-donation donor self-exclusion, in combination with virological
screening has successfully reduced transfusion transmitted HIV be-
cause the questions asked prior to donation effectively target at-risk
43. In the United States, because of the successful use of antibody tests for blood donor
screening and the exclusion of high risk donors, the residual risk of HIV transmission by blood
transfusion is approximately 0.0002%, or twenty per million.  Eberhard Fiebig, Safety of the
Blood Supply, 357 CLINICAL ORTHOPAEDICS & REL. RES. 6, 11 (1998); see also SCHOUB, supra
note 19, at 153 (The combination of pre-donation and serological screening in the United States
has reduced “the risk of infection from blood donated during the window period to [only on] the
order of one in a million.”).  “Of 12 million units of donated blood each year, 10 HIV infected
units slip through, accounting for two to three cases of donor transmitted HIV infections a
year.”  Deborah Josefson, FDA Declines To Lift Ban on Homosexual Men as Blood Donors,
321 BRIT. MED. J. 722, 722 (2000).
44. See Fiebig, supra note 43, at 6, 11.
45. Id. at 12.
46. Jean-Jaques Lefrère et al., Interviews with Anti-HIV-Positive Individuals Detected
through the Systematic Screening of Blood Donations: Consequences on Predonation Medical
Interview, 62 VOX SANG 25, 26 (1992) (emphasis added).
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populations.47  Thus, even if the screening categories are overbroad
and screen out many individuals who do not pose a high risk of
transmitting HIV, they effectively screen out those individuals who
pose a high risk of transmitting HIV.
In developing countries, the risk of transfusion-transmitted HIV
infection is significantly higher than in developed countries.48  The
South African Law Commission found that even after pre-donation
donor self-exclusion, 0.56% (5.6 in every 1000) of blood donations
were HIV-positive.49  The disparity in screening effectiveness between
developed and developing countries is due in part to the fact that in
developing countries, especially those in sub-Saharan Africa, it is of-
ten difficult to define low risk populations because “all sexually active
persons” are effectively high risk individuals.50  The disparity in
screening effectiveness is also due to the increased seroprevalence in
the countries’ overall populations.51  Thus, developing countries that
seek to reduce the transmission of HIV by blood transfusion face the
difficult task of setting parameters for self-exclusion (defining which
groups are high and low risk) so that individuals who are HIV-
positive at the time of donation or who are likely to seroconvert after
donation are deterred from becoming blood donors.  Because exclu-
sionary criteria are intended to screen out individuals with a high risk
of infection, the definition of what constitutes high risk may be broad
and over-inclusive, necessarily excluding more individuals from do-
nating blood than are infected.
The task of narrowly defining criteria for blood donation self-
exclusion is conceptually challenging and often times legally prob-
lematic.  For example, within the past year alone, public health policy
makers in the United States and South Africa have come under scru-
47. See Fiebig, supra note 43, at 6, 11; see also L.S. Doll et al., Human Immunodeficiency
Virus Type-1 Infected Blood Donors: Behavioral Characteristics and Reasons for Donation, 31
TRANSFUSION 704, 707 (1991).
48. SCHOUB, supra note 19, at 153; see also McFarland et al., supra note 38, at S98.
49. Out of 7,078,333 blood donations tested for HIV between 1985 and mid-1994, 39,777
blood donations were HIV positive.  See Ngwena, supra note 32, at 159 (citing South African
Law Commission, Aspects of the Law Relating to AIDS, Working Paper No. 171, 1995).
Ngwena’s statistical analysis is incorrect: after providing the numbers of blood donations, he
states 0.0056% rather than 0.56%.  Ngwena did not report the epidemiology of HIV infection
among infected blood donors.  Information on the seroprevalence rates of HIV among infected
donor populations would facilitate adoption of more effective exclusionary criteria, because
questions could be asked to exclude groups among whom seroprevalence is high.
50. Gerard, supra note 18, at 48.
51. William McFarland et. al., Risk Factors for HIV Seropositivity Among First-Time Blood
Donors in Zimbabwe, 38 TRANSFUSION 279, 279 (1998).
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tiny because of restrictions on blood donation by MSM.52  Opponents
of the restrictions assert that any prohibition on blood donation by
MSM constitutes discrimination on the basis of sexual orientation
and, therefore, is unjustifiable.53  Public health policy makers, how-
ever, counter that these restrictions are necessary to protect the safety
of the blood supply and thus constitute a justifiable measure, albeit
one which appears discriminatory.54
This debate effectively highlights the fundamental conflict be-
tween the paradigmatic goals of public health and law.  Public health,
specifically epidemiology, is concerned predominately with popula-
tions and public welfare, whereas law and the clinical practice of
medicine are concerned with individuals.55  Because public health
policies are adopted to maximize community health, they often do
not privilege individual interests.56  A public health policy thus may
appear to be overbroad in a legal analysis, while epidemiologists view
it as a reasonable preventive measure.
III.  COMPARATIVE NATIONAL PRACTICE
The practices adopted by various countries to protect and main-
tain blood supplies free of HIV and other viral contaminants, such as
hepatitis, arguably do not constitute customary international law be-
cause of a lack of opinio juris.57  These practices thus are not binding
52. FDA Panel, supra note 4, at A29; Harvey, supra note 4.
53. FDA Panel, supra note 4, at A29.
54. Id.
55. See LAWRENCE O. GOSTIN, PUBLIC HEALTH LAW: POWER, DUTY, RESTRAINT 13
(2000).
56. Id. at 14–15.
57. A full discussion of whether the practices adopted to protect and maintain clean and
safe blood supplies constitute customary international law is beyond the scope of this paper.
However, a brief outline of such an argument follows.
Article 38 of the Statute of the International Court of Justice defines customary interna-
tional law as comprised of a state’s acts, state practice, and a given state’s intent and belief that
those acts are obligatory acts under international law, opinio juris.  PETER MALANCZUK,
AKEHURST’S MODERN INTRODUCTION TO INTERNATIONAL LAW 39 (7th rev. ed. 1997); see
also Military and Paramilitary Activities (Nicar. v. U.S.), 1986 I.C.J. 14, 97 (June 27).  State
practice refers not only to a state’s conduct regarding foreign affairs, but also to its domestic af-
fairs, for example national legislation, judicial decision, and policy.  1 OPPENHEIM’S
INTERNATIONAL LAW 26 (Robert Jennings & Arthur Watts eds., 9th ed. 1992).  A state’s ac-
tions only become state practice or part of custom when they are committed “under the aegis of
the conviction that these actions are, according to international law, obligatory or right.”  Id. at
27; see also North Sea Continental Shelf Cases (F.R.G. v. Den.; F.R.G. v. Neth.), 1969 I.C.J. 3,
44 (Feb. 20).  The International Court of Justice in the North Sea Continental Shelf Cases em-
phasized that for a state’s acts to be considered to have the requisite opinio juris, two necessary
preconditions must be satisfied: “Not only must the acts concerned amount to a settled practice,
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on other states. The legal and policy practices of other countries,
however, are often instructive in developing and analyzing law and
policy.
This section presents a comparative analysis of the policies of the
United States, Canada, Denmark, Australia, Uganda, and Singapore,
concerning blood donations, transfusions, and HIV-transmission pre-
vention.  The United States, Canada, Denmark, and Australia are
categorized as Pattern One countries because the majority of sexually
transmitted HIV infections in these countries result from homosexual
contact.58  Uganda and Singapore, on the other hand, are categorized
as Pattern Two countries because the majority of sexually transmitted
HIV infections result from heterosexual contact.59
This section focuses on policies concerning pooled blood dona-
tions rather than autologous or directed donations.  Autologous do-
nation refers to an individual donating blood that he or she will use at
a later date.  Directed donation refers to an individual soliciting blood
donationS from friends or family.  This policy is disfavored because of
confidentiality concerns, and because individuals who would other-
wise defer from blood donation because of high risk behavior might
feel compelled to donate blood for a relative or friend.60
Each section below chronicles the development of law and policy
from the early identification of HIV/AIDS within the state’s blood
but they must also be such, or be carried out in such a way, as to be evidence of a belief that this
practice is rendered obligatory by the existence of a rule of law requiring it.”  North Sea Conti-
nental Shelf, at 44.
It is highly doubtful that national blood donation policies implemented to prevent the fur-
ther transmission of HIV and the inclusion therein of specific exclusionary criteria could satisfy
the preconditions of state practice and opinio juris sufficient to constitute customary interna-
tional law.  For the most part, states draft these policies with an eye towards the national public
health.  Furthermore, even if these policies are drafted in harmony with the policies of other
countries, or international best-practice, it is unlikely that such practice alone could substantiate
a claim of international law because of the marked lack of opinio juris.
58. Dr. Jonathan Mann described the pattern of HIV/AIDS in North America, Western
Europe, Australia, and New Zealand as Pattern One.  He wrote: “In these areas, the sexual
transmission of the virus is predominantly homosexual although heterosexual transmission has
been, and is continuing to occur.  In these areas, HIV transmission by blood transfusion is pre-
vented because blood transfusions are screened, but bloodborne spread is still occurring
through sharing of needles and syringes among persons with self-injecting behaviours.  Finally in
these areas of the world there is transmission from mother to child but . . . there are relatively
fewer instances of transmission to children.”  Jonathan Mann, Worldwide Epidemiology of
AIDS,  in THE GLOBAL IMPACT OF AIDS 4 (Alan F. Fleming et al. eds., 1988).
59. Id.
60. Ronald Bayer, Blood and AIDS in America: Science, Politics, and the Making of an Iat-
rogenic Catastrophe, in BLOOD FEUDS: AIDS, BLOOD, AND THE POLITICS OF MEDICAL
DISASTER 20, 26 (Eric A. Feldman & Ronald Bayer eds., 1999).
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supply to the establishment of comprehensive protocols for prevent-
ing transfusion-related transmission of HIV.  Where available, the le-
gal prescriptions that mandate specified policies are presented.  These
case studies provide examples of measures implemented to prevent
the continued spread of HIV through blood and blood products, and
the policy decisions that led to their formulation.  The United States
features prominently in this analysis and is a point of departure and
reference because of the availability of information on the formation
of blood donation policy and the availability of research on its effi-
cacy.
A. United States
In July 1982, the U.S. Centers for Disease Control (CDC)61 is-
sued a warning to blood bank agencies and hemophiliacs that the re-
cently identified disease AIDS was caused by a blood-borne patho-
gen.62  By the end of 1982, over 400 cases of AIDS had been
diagnosed in the United States predominately among homosexual
men, Haitians, intravenous drug users, and hemophiliacs.63  The CDC
urged that precautionary measures be implemented to stave off fur-
ther spread of the disease.64
Throughout 1982, researchers found increasing evidence indi-
cating that AIDS was blood-borne and could be transmitted by blood
61. The U.S. Public Health Service (USPHS), housed within the Department of Health and
Human Services, is responsible for national public health.  James G. Hodge, Jr., The Role of
New Federalism and Public Health Law, 12 J.L. & HEALTH 309, 337 (1998).  The USPHS was
originally the Marine Hospital Service; it was renamed in 1912.  Since that time, the USPHS has
grown from administering health services to marines to administering many of the operative
agencies of the United States Department of Health and Human Services (DHHS) including
the CDC, the National Institutes of Health (NIH), the Food and Drug Administration (FDA),
and the Human Resources and Services Administration (HRSA).  Id.  The specific responsibil-
ity for developing policies to ensure the quality and safety of the blood supply was delegated
under the United States Public Health Act of 1944 to the Center for Biologics Evaluation and
Research.  42 U.S.C. § 241 (2001).  The FDA implements policies drafted by the Center for Bi-
ologics Evaluation and Research through federal regulations.
62. ANDRÉ PICARD, THE GIFT OF DEATH: CONFRONTING CANADA’S TAINTED-BLOOD
TRAGEDY 56 (1995).
63. Id. at 57.
64. “The CDC has no direct regulatory power.  It provides epidemiologic information and
technical support to other regulatory agencies and information to medical providers and the
public, but relies on the FDA and other Public Health Service agencies to implement its rec-
ommendations.  It issued regular surveillance reports and initiated meetings of blood banks,
manufacturers, and the FDA during the early 1980s, but its recommendations were often ig-
nored in the face of opposition from powerful interest groups, especially blood bankers and gay
rights activists.”  Sherry Glied, Markets Matter: U.S. Responses to the HIV-Infected Blood Trag-
edy, 82 VA. L. REV. 1493, 1495–96 (1996).
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transfusion.  In July 1982, the CDC reported that three hemophiliacs
had died of AIDS-related infections; none of the infected individuals
had any risk factor other than that they had received blood transfu-
sions.65  In December 1982, the CDC reported that five more hemo-
philiacs had contracted AIDS, and that there were five other AIDS
cases that might have resulted from blood transfusions.66
The Hemophilia Foundation proposed in 1982 that blood banks
proscribe donations by gay men.67  However, because they did not
want to foster an exclusionary policy, and because gay men were con-
sidered “crucial to the donor pool,”68 blood banks did not implement
this proposal immediately.  Dr. James Curran, the director of AIDS
activities at the CDC urged the gay community to seize the “political
initiative with a call for voluntary withdrawal of all gay men from the
donor pool.”69  He stated, “The thing is, people are dying.  The medi-
cal problem is more important than the civil rights issue.”70  Despite
Dr. Curran’s recommendations, however, the blood banking agencies
in the United States (the American Association of Blood Banks, the
American Red Cross, and the Council of Community Blood Banks)
expressly rejected pre-donation screening on the basis of sexual ori-
entation, so as not to discriminate against MSM.71
In March 1983, the U.S. Food and Drug Administration (FDA)
issued recommendations that “members of groups at increased risk
for AIDS should refrain from donating plasma and/or blood.  This
recommendation includes all individuals belonging to such groups,
even though many individuals are at little risk of AIDS.”72  Groups
that were excluded from blood donation included “men who had sex
with men, members of the Haitian community, injection drug users,
65. Bayer, supra note 60, at 20–21.
66. Id. at 22.
67. Id. at 23.
68. Id.  Gay men were crucial to the donor pool because “[p]rior to AIDS, gay people used
to go in together to donate blood, as a community effort.”  Melinda Tuhus, Supplies of Blood
Fall as Demand Increases, N.Y. TIMES, Oct. 29, 2000, § 14CN (Conn. Ed.), at 3.  Few other
groups donated with the solidarity that gay men did prior to the mid-1980s.
69. THE ADVOCATE, Feb. 17, 1983, at 9, quoted in Bayer, supra note 60, at 23.
70. Bayer, supra note 60, at 23.
71. Id. at 24.
72. Food & Drug Administration, Recommendations to Decrease the Risk of Transmitting
Acquired Immune Deficiency Syndrome (AIDS) from Blood Donors, Memorandum from the
Director, Office of Biologics, National Center for Drugs and Biologics (Mar. 24, 1983), quoted
in Inge B. Corless et al., Perspectives in Conflict: The Response to Transfusion-Associated AIDS,
14 AIDS & PUB. POL. J. 47, 59 (1999).
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and the sexual partners of any of those individuals.”73  All of these
groups had high AIDS prevalence rates at the time.74  The U.S. Public
Health Service (USPHS) issued these recommendations to comply
with federal regulations mandating that blood donors be “free[ ] from
any disease transmissible by blood transfusion,”75 and because there
was “no alternative but to treat all members of groups at increased
risk for AIDS as posing a threat of transmission.”76
Diagnosis of AIDS prior to the onset of the symptomatic illness
was almost impossible before the identification of HIV and the crea-
tion of screening tests.  Furthermore, the latency or “window period”
between exposure to the infection and illness was lengthy, necessi-
tating other screening measures because “the pool of persons poten-
tially capable of transmitting an AIDS agent may be considerably
larger than the presently known number of cases.”77  While status-
based classifications to exclude donors generally are disfavored be-
cause of their lack of specificity, the utility of these classifications “ul-
timately depends upon the strength of the relationship between status
and behavior.”78  For example, if there is a high prevalence of HIV in
a MSM population, the error associated with exclusionary criteria
based on MSM behavior is less.79  An exclusionary criteria based on
MSM behavior, however, is functionally identical to a status-based
classification.  The use of exclusionary criteria closely resembling
status-based classifications ultimately was validated by epidemiologi-
cal data that showed the large prevalence of HIV/AIDS infection in
MSM populations in the 1980s.80
73. Norbert Gilmore & Margaret Sommerville, From Trust to Tragedy: HIV/AIDS and the
Canadian Blood System, in BLOOD FEUDS: AIDS, BLOOD, AND THE POLITICS OF MEDICAL
DISASTER 128, 134 (Eric A. Feldman & Ronald Bayer eds., 1999); see also Bayer, supra note 60,
at 25.
74. See infra text accompanying notes 81, 85.
75. 21 C.F.R. § 640.3(a)(c) (2000); see also 21 C.F.R. § 640 (2000) (regulating donor suit-
ability).
76. Bayer, supra note 60, at 25.
77. Id. (quoting Centers for Disease Control, Prevention of Acquired Immune Deficiency
Syndrome (AIDS) Report of Interagency Recommendations, MORBIDITY AND MORTALITY
WKLY. REP. 101–03 (Mar. 4, 1983)).
78. Steven R. Salbu, AIDS and The Blood Supply: An Analysis of Law, Regulation, and
Public Policy, 74 WASH. U. L.Q. 913, 954 (1996).
79. Id.
80. See infra text accompanying notes 81–85.
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After the identification of HIV in early 1984, testing of blood
donations became widely available.81  The American Red Cross re-
ported that soon after testing began, one in 500 U.S. donors tested
positive for HIV.82  In New York City, “87% of intravenous drug us-
ers [at a drug clinic] tested positive.”83  The infection rate in San Fran-
cisco among healthy, apparently uninfected gay men was 55%; among
gay men tested in New York City, the infection rate was 38%.84  HIV
tests of apparently uninfected hemophiliacs “revealed that 72% were
infected; among those who infused Factor VIII more than once a
month, the infection rate was 90%.”85
In 1985, blood banks initiated universal testing of blood dona-
tions.86  Potential blood donors were informed that their blood would
be tested for antibodies to HIV. 87  If donors tested HIV-positive, they
were notified confidentially.88  “Neither blood banks nor donors could
elect to avoid such notification.”89  After pre-donation blood donor
screening was implemented in 1985, a study was done evaluating
blood donors who tested HIV positive.90  Of 818,629 blood donations
included in the study, 450 (or 0.05%) donors were HIV positive.91
During 1985–1986, the year in which the study was conducted, sero-
81. Bayer, supra note 60, at 31–32.  Serological screening of blood donations was not avail-
able prior to 1984 because although HIV, the virus that causes AIDS, was identified in 1983, the
virus was not propagated in a cell culture until 1984.  Only after propagation of HIV in the labo-
ratory could diagnostic serological tests to specifically target HIV antibodies be developed.  See
SCHOUB, supra note 19, at 10.  The first serological test kit to detect HIV antibodies was li-
censed by the FDA for use in March 1985.  Corless et al., supra note 72, at 47; see also Lisa M.
Korsten, Note, The Global Market For Blood: A Proposal For Expansion and a Consistent Sys-
tem of International Regulation, 11 B.U. INT’L L.J. 227, 238 n.74 (1993).
82. PICARD, supra note 62, at 66.
83. Id.
84. Id.
85. Id.  Factor VIII is a protein extracted from blood products which promotes blood clot-
ting and frequently is given to hemophiliacs.  If blood products (i.e., lymphocytes or monocytes)
containing HIV or other viral contaminants are used in the production of Factor VIII, the virus
will be transmitted to all individuals receiving the product.  SCHOUB, supra note 19, at 111–12.
Factor VIII infusion by hemophiliacs compounded the incidence of HIV infection in the hemo-
philiac population because large numbers of individuals were exposed prior to knowledge of
HIV contamination or the implementation of preventative measures.  See Bayer, supra note 60,
at 22, 29–31, 44.
86. Prior to 1985, the United States did not have any regulatory policy in place that ad-
dressed blood donation screening.  See Glied, supra note 64, at 1506.
87. Bayer, supra note 60, at 32.
88. Id.
89. Id.
90. J. W. Ward et al., Epidemiologic Characteristics of Blood Donors with Antibody to
Human Immunodeficiency Virus, 28 TRANSFUSION 298, 298 (1988).
91. Id.
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prevalence among donors declined from 0.07% to 0.04%.92  Seventy-
seven percent (77%) of the seropositive men interviewed reported
sexual contact with men; of this 77%, 53% identified themselves as
bisexual.93  As a result of the coordinated use of antibody testing and
pre-donation screening, the residual risk of HIV transmission by
blood transfusion in the United States since 1985 has been reduced to
virtually none. 94
A residual risk of transfusion-transmitted HIV still exists in the
United States, albeit minimal.  The risk remains because blood do-
nated in the window period may not test positive for antibodies to the
virus even while there is a high viral load present in the blood.95  To
ensure that the risk remains as low as possible, the United States con-
tinues to enforce strict pre-donation screening criteria.96  Stringent cri-
teria are also in place because of the extensive litigation that ensued
after incidences of transfusion-related transmissions of HIV.97  Pre-
donation screening using donor self-exclusion questionnaires, while
not required by law, is used in all blood donation programs in the
United States.98  The questionnaires are used in combination with se-
rological screening of all blood donations for HIV and other blood
borne pathogens; serological screening is mandatory in the United
States.99
The FDA further restricted the pre-donation blood donor exclu-
sion system in 1990 by reducing the pool of potential donors.  Dr.




94. See Fiebig, supra note 43; see also George B. Schreiber et al., The Risk of Transfusion-
Transmitted Viral Infections, 334 NEW. ENG. J. MED. 1685 (1996).
95. Dr. Michael Busch of the University of California at San Francisco says that “of the
nation’s 12 million units of donated blood, about 10 HIV-infected units are undetected each
year, causing about two or three HIV infections annually.” FDA Panel, supra note 4.
96. See Bayer, supra note 60, at 53.
97. See generally id. at 34–52.
98. United States Blood Donation Questionnaire (on file with the Duke Journal of Com-
parative and International Law).
99. 21 C.F.R. § 610.45 (2000) ((a) Testing Requirements.  (1) Each donation of human
blood or blood components intended for use in preparing a product shall be tested for antibody
to HIV by a test approved for such use by the FDA, except as otherwise approved in writing by
the FDA. . . .”); 21 C.F.R. § 640.3 (2000).  As early as 1985, some individual states in the U.S.,
like Washington, had implemented legislation requiring systematic screening of blood dona-
tions, prior to the passing of a national law.  D. Reviron et al., Prevention of HIV Infection by
Transfusion: Comparative Analysis of Systems Adopted in Developed Countries, 6 AIDS & PUB.
POL. J. 25, 25 (1991).
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The strengthened program will enhance . . . the current procedures
used to safeguard the blood supply.  By shifting the focus of
screening procedures to cover a broader range of risk factors, FDA
will build upon the safety of the blood supply while providing all
healthy and willing individuals the opportunity to donate blood.100
The FDA continued to mandate that each blood donation be tested
for HIV and other blood-borne infectious agents.101  In addition, the
FDA urged blood donation centers to implement the following meas-
ures:
1. Blood establishment personnel should talk with each candidate
donor to ensure comprehension concerning the risk of HIV in-
fection, i.e., information about these risks is available in the
language appropriate to each donor and is constructed to be
culturally sensitive to promote comprehension.  The focus
should be on behavior and not on stereotypes (e.g., many men
who have had male-to-male sexual experiences do not identify
themselves as “homosexual,” “gay,” or “bisexual”).
2. The oral and/or written interaction between potential donors
and blood establishment personnel should include direct ques-
tions about risk behaviors for HIV infection. . .102
Although these measures have proven effective in reducing the num-
ber of infected blood donors and thus the incidence of transfusion-
related transmission of HIV,103 many scientists and gay activists be-
lieve that the measures have not satisfied their goal of specifically tar-
geting high risk behaviors rather than stereotypes.104  The latter con-
cern was addressed specifically when an FDA advisory panel
reviewed whether or not to change the ban on blood donations by
men who have sexual contact with other men.105
Under the FDA’s rules for blood donation, men who have had
sexual contact with other men even just once since 1977 are prohib-
ited from donating blood in the United States.  This exclusionary cri-
100. Press Release, Brad Stone, Food and Drug Administration, New Blood Policy (Dec. 5,
1990) (on file with the Duke Journal of Comparative and International Law).
101. Id.
102. Id. (emphasis added.)
103. S. A. Glynn et al., Trends in Incidence and Prevalence of Major Transfusion-
Transmissible Viral Infections in US Blood Donors, 284 JAMA 229 (2000) (finding that from
1992 to 1996 HIV prevalence declined in first-time donors from 0.030% to 0.015% (P=.006); this
combined with “the decrease in HIV and HCV prevalence rates, [and] the . . . lower rates of
infection in first-time donors compared with the general population, suggests the continued
benefit of behavioral risk factor screening”).
104. Deborah Josefson, FDA Declines to Lift Ban on Homosexual Men As Blood Donors,
321 BRIT. MED. J. 722 (2000).
105. Id.; see also FDA Panel, supra note 4.
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terion has been criticized as discriminatory and inapposite, especially
since HIV seroprevalence among gay men has declined to approxi-
mately 8%.106  Whether MSM should continue to be excluded from
blood donation in the United States has generated extensive recent
debate.
Scientists and gay activists urged the FDA to change the current
restrictions to prohibit only blood donations from men who have en-
gaged in homosexual activities within the past five years.107  The pro-
posed revised blood donation restrictions would not prohibit dona-
tions from “men who have had gay sex only once” or men who have
not engaged in same sex activities in the past five years.108  The revi-
sions would enable approximately 62,300 gay males to qualify as do-
nors.  An FDA medical official estimates that should these individu-
als be allowed to donate blood, only approximately 1.7 units of HIV
infected blood would enter the blood supply each year.109
Scientists from the FDA and the CDC maintained, however, that
the present ban should remain in force, and that it is justified by the
epidemiology of HIV transmission in the United States.110  Despite a
decline in seroprevalence among MSM, and projections that the eas-
ing of the restrictions would not significantly increase the incidence of
transfusion-related HIV infection, an advisory panel of the FDA
voted in 2000 to maintain the more restrictive ban.111  The FDA and
the CDC publicly stated, however, that they consider the exclusionary
policy to be based on behavior and epidemiology rather than on sex-
ual identity.112
The United States’ blood donation policy embodies the com-
promises necessary between public health and individual rights, which
are encountered frequently when formulating public health regula-
tion or policy in a democratic political society.113  Public health focuses
on the development of policies to protect individuals’ health within
the society through collective action.114  The government must have a
106. FDA Panel, supra note 4; see also U.S. DEPARTMENT OF HEALTH & HUMAN
SERVICES, FOOD & DRUG ADMINISTRATION, CENTER FOR BIOLOGICS EVALUATION &
RESEARCH, BLOOD DONOR SUITABILITY WORKSHOP 9 (Nov. 23, 1998).
107. FDA Panel, supra note 4; Harvey, supra note 4.
108. See FDA Panel, supra note 4.
109. Id.
110. Stone, supra note 100.
111. FDA Panel, supra note 4.
112. Josefson, supra note 104, at 722.
113. See generally GOSTIN, supra note 55, at 7–22, 85–109.
114. Id. at 12.
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legitimate justification for the public health interventions that it im-
plements.115  There is a general presumption, subject to judicial scru-
tiny, that these interventions are justified if they minimize the overall
risk of harm to citizens’ health.116  For example, the United States Su-
preme Court in Jacobson v. Massachusetts117 held that compulsory
vaccination is a legitimate use of the state’s police power.118  Jacob-
son’s liberty interest was not violated by compulsory vaccination be-
cause in the United States’ constitutional system, liberty is not abso-
lute.119  As the Court stated, “There are manifold restraints to which
every person is necessarily subject for the common good.”120  The
Court held that the restraint in Jacobson, and the risk of a consequent
“injury [to Jacobson’s liberty interests was] too small to be seriously
weighed as against the benefits coming from the discreet and proper
use of the preventive.”121  To public health policy makers in the
United States, the risk of harm associated with HIV, of acquiring a fa-
tal or potentially fatal disease from a blood transfusion, far outweighs
the costs of pre- and post-donation screening or any consequent in-
fringement on liberty interests or personal autonomy in denying
someone the opportunity to donate blood.122
Recent revisions in restrictions demonstrate the extent to which
public health protections are favored over other interests, such as ex-
panding the pool of potential blood donors, even when the exclusion-
ary criteria are seemingly arbitrary or discriminatory.  Responding to
the threat of transfusion-related transmission of new variant
115. Id. at 72.
116. See generally id. at 77–82.
117. 197 U.S. 11 (1905).
118. See GOSTIN, supra note 55, at 66–70.
119. Jacobson, 197 U.S. at 26 (“The liberty secured by the Constitution of the United States
to every person within its jurisdiction does not import an absolute right in each person to be, at
all times and in all circumstances, wholly free from restraint.”).
120. Id.
121. Id. at 24.
122. See generally GOSTIN, supra note 55, at 86–100.  A right to donate blood has not been
recognized by courts or legislatures in the United States.  Raso v. Moran, 551 F. Supp. 294, 297
(D.R.I. 1982) (“The plaintiff does not, and indeed could not, contend that he maintains a liberty
interest in giving blood that is based on the Constitution itself.”); see also Bishop v. Ventetuolo,
C.A. No. 90-0497B, 1991 U.S. Dist. LEXIS 19307, at *9 (D.R.I. Dec. 5, 1991) (holding that
where a prisoner participates in a blood donation program so that his sentence is reduced by ten
days for each pint of blood donated, his “expectation [of continued participation] amounts to a
protected liberty interest in the donation of blood.  Before an inmate can be denied the oppor-
tunity to participate in the blood donation program, he must be provided notice, an opportunity
to submit written evidence as to his health, status, and a statement of reasons for his disqualifi-
cation from the program.”).
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Creutzfeldt-Jakob disease (nv-CJD), now referred to as variant-CJD
(vCJD),123 the FDA imposed restrictions on blood donation by indi-
viduals who spent more than six months in the United Kingdom be-
tween 1980 and 1997.124  These restrictions have eliminated up to 4%
of eligible blood donors in certain states.125  The FDA imposed these
restrictions despite a lack of evidence supporting them as an appro-
priate prevention: only ninety definite cases of vCJD have been diag-
nosed, eighty-seven of which were in the United Kingdom.126  None of
the reported cases resulted from exposure to blood products; in fact
vCJD has been transmitted by blood only in experimental circum-
stances using animal subjects and direct injection.127  Transmission was
123. Variant CJD is caused by the same infectious agent, prion protein, as that which causes
bovine spongiform encephalophathy (BSE) or mad cow disease.  See Litjen Tan et al., Risk of
Transmission of Bovine Spongiform Encephalopathy to Humans in the United States: Report of
the Council on Scientific Affairs, 281 JAMA 2330–39 (1999); see also Center for Biologics
Evaluation and Research, Draft Guidance: Revised Preventive Measures to Reduce the Possible
Risk of Transmission of Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products, at 1
(Aug. 2000), available at http://www.fda.gov/cber/gdlns/cjdvcjd.pdf (last visited Oct. 8, 2001).
124. Scott Gottlieb, FDA Bans Blood Donation By People Who Have Lived in UK, 319
BRIT. MED. J. 535 (1999).  Restrictions are in place to prevent against the spread of other blood
borne diseases.  See supra text accompanying notes 24–27.  On August 27, 2001 the FDA issued
revised draft guidance “intended to further reduce the risk of transmission of [vCJD] to recipi-
ents of blood and blood products.”  Press Release, Food and Drug Administration, FDA Issues
Draft Guidance to Further Reduce the Possible Risk of Transmission of Variant Creutzfeldt-
Jakob Disease By Blood and Blood Products (Aug. 27, 2001), available at http://www.fda.gov/
bbs/topics/NEWS/2001/NEW00768.html (last visited Oct. 8, 2001) [hereinafter Draft Guidance
Press Release].  The revised guidance recommends changes to be implemented by May 31, 2002
to “expand the donor deferrals that have been recommended since August 1999 for donors who
have lived or traveled in the U.K.”  Id.  The proposed changes include deferral of donors who
(1) have spent three or more cumulative months in the U.K. from 1980 through the end of 1996;
(2) were stationed at U.S. military bases in Europe from 1980 through 1996; (3) have lived for a
cumulative period of five years or more in France since 1980; or (4) received a blood transfusion
in the U.K. at any time since 1980.  Id. at 1–3.  The additional deferral of individuals who have
lived for a cumulative period of five years or more in other countries in Europe since 1980,
would take effect on October 31, 2002.  Id. at 3.  The FDA recommends implementation of the
deferral criteria despite the fact that “vCJD is not known to have been transmitted by blood
transfusion.”  Id. at 1.
125. Tuhus, supra note 68.
126. Paul Brown et al., Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob
Disease: Background, Evolution, and Current Concerns, 7 EMERGING INFECTIOUS DISEASE 6,
11 (2001) (Two cases of vCJD were confirmed in France and one case was confirmed in the Re-
public of Ireland.); see also Tan et al., supra note 123, at 2335 (“Although WHO and the EU
state that transmission of CJD via blood cannot currently be confirmed and too few data on nv-
CJD exist to make recommendations, they advocate exclusion of blood donation by people who
have or are at risk for CJD.”).
127. See Draft Guidance Press Release, supra note 124, at 1; see also Gottlieb, supra note
124, at 535; F. Houston et al., Transmission of BSE by Blood Transfusion in Sheep, 356 THE
LANCET 999, 1000 (2000).
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reported when vCJD was injected into mice brains,128 and when whole
blood was transfused from an infected sheep to a previously unin-
fected sheep.129
The FDA has adopted “an extremely conservative approach to
guidelines on blood and blood products.”130  Although no cases of
transfusion-transmitted vCJD have been reported or are believed to
have occurred, and there is a total “lack of data on vCJD transmission
via plasma,” the FDA proscribed donation from people who might be
at risk of acquiring vCJD.131  According to researchers, the limited
threat posed by vCJD is “in public health terms . . . compelling
enough to warrant action by relevant US authorities.”132
The cautious approach to public health policy and regulation in
the United States is unlikely to change as demonstrated by the recent
campaign by scientists and gay activists to change the restrictions on
blood donation by MSM.  A scientific advisory panel of the FDA on
September 15, 2000 voted seven to six against changing the rule ban-
ning blood donation from men who have had sex with another man
since 1977, to a ban on MSM contact within the five years prior to
donation. 133  The panelists who voted against the rule change, how-
ever, urged scientists to study any potential effects of the proposed
changes in policy.134  Although only an estimated 8% of MSM in the
United States are HIV-positive, male-male sexual contact still is con-
sidered “a leading risk factor for HIV infection” in the United
States.135  MSM contact is considered a significant risk factor in part
because “[d]espite the current questioning of donors and use of exclu-
sion criteria, a study of nineteen large U.S. blood centers revealed
that 43% of all donations discarded because they were HIV-positive
came from men who reported a history of male-male sexual con-
tact.”136  Epidemiologists assert that these data “support the need to
continue interviewing potential donors about behavior that presents a
risk of HIV transmission.”137  Scientific advisors to the FDA thus did
128. Gottlieb, supra note 124, at 535.
129. Houston et al., supra note 127, 1000.
130. Tan et al., supra note 123, at 2338.
131. Id. at 2335.
132. Id.
133. FDA Panel, supra note 4.
134. Id.
135. Eve M. Lackritz et al., The Risk of HIV Transmission By Screened Blood, 334 NEW
ENG. J. MED. 992, 993 (1996).
136. Id.
137. Id.
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not consider the risk of HIV transmission minimal enough to change
policy.  In the United States, to justify a public health regulation, the
risk of harm may be quite limited so long as the consequence is sig-
nificant.  Because blood transfusion is a highly effective means of
transmitting HIV, and MSM contact is a significant risk factor for
HIV, blood donations by MSM are proscribed although the chance of
such a transmission occurring is rare.138
B. Canada
The AIDS epidemic emerged in Canada at roughly the same
time as in the United States.  In 1982, when over 400 cases of AIDS
had been diagnosed in the United States, only eight cases had been
identified in Canada, the majority of which resulted from homosexual
transmission.139  In subsequent years, the number of afflicted individu-
als dramatically increased, as did the number of individuals who were
infected by blood transfusion. 140
In 1983, the Canadian Hemophilia Society’s Medical and Scien-
tific Advisory Committee (MSAC) issued recommendations to the
Red Cross Blood Transfusion Service of Canada (CRCBTS) “to re-
duce the risk of AIDS in the blood supply.”141  That same year, the
Canadian Red Cross Society (CRCS), organized under the League of
Red Cross Societies (League),142 publicly asked “homosexual and bi-
sexual men with multiple partners to abstain from giving blood, along
with newly arrived Haitian immigrants and intravenous drug users.”143
Although the CRCS’s appeal was a targeted intervention following
138. See Gostin, supra note 55, at 94–95.
139. PICARD, supra note 62, at 57.
140. Id. at 57–60.
141. Id. at 72.  The recommendations read as follows:
a) serious efforts should be made to exclude blood donors who might transmit AIDS,
including: 1) an education campaign to promote self-exclusion by donors belonging to
high-risk groups, such as male homosexuals and Haitian immigrants, with the coopera-
tion of the leadership of these groups; 2) specific questions on the blood donor ques-
tionnaire to detect symptoms associated with AIDS, such as swollen lymph glands,
night sweats or unexplained fever or weight loss; 3) evaluation and implementation of
laboratory tests that would identify individuals at high risk of AIDS transmission.
Id.
In Canada at this time, and until 1987, the Canadian Red Cross Society and under its ad-
ministration the CRCBTS were run as voluntary organizations independent of government
regulation or intervention.  1 THE HONORABLE MR. JUSTICE HORACE KREVER, FINAL
REPORT, COMMISSION OF INQUIRY ON THE BLOOD SYSTEM IN CANADA 51 (1997) [hereinafter
KREVER REPORT].
142. Id.
143. PICARD, supra note 62, at 73.
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MSAC protocol—the groups targeted were high risk: 61% of diag-
nosed AIDS cases were among homosexual men, and 37% were
among Haitian immigrants—response to the CRCS was highly criti-
cal.144  Gay and Haitian organizations filed discrimination complaints
and boycotted clinics, emphasizing civil rights concerns rather than
blood safety.145  The CRCS ultimately withdrew from the donor self-
exclusion questionnaires any question addressing whether a potential
donor had engaged in high risk practices, or whether they suffered
from any symptom resembling HIV or AIDS.146  The only diagnostic
question permitted was “Are you well?”147  The CRCS withdrew its
interventions to comply with the League’s principles of impartiality
and neutrality.  The principles proscribe discrimination “against indi-
viduals on the basis of their race or nationality or [causing] contro-
versy about a group of people.”148
Physicians and lawyers affiliated with the CRCS reacted strongly
against the drafting of a questionnaire that ignored risk factors for the
disease in order to conform with League anti-discrimination princi-
ples.  Michael Worsoff, the lawyer for the CRCS, was asked at a
March 29, 1983 meeting of the AIDS Working Group, “What would
be the legal aspects if an issue is made of the right of donors to give
blood?”149  He responded:
It is not a matter of the donor having a right to donate blood.
Rather, it is a case of the Red Cross having both a moral and legal
obligation to assure the safety of the blood it accepts for processing
and distribution.  The evidence of possible unacceptability of the
blood does not have to be conclusive, the decision can be made on
a basis of ‘reasonable doubt’ as to its suitability.  With reference to
the AIDS problem in particular, the premise is not that the CRC
has to justify beyond any scientific doubt that there is a link be-
tween designated ‘high risk groups’ and the development of AIDS
since, if there is even a possibility of transmission via blood, the
CRC has the moral and legal obligation to protect the recipient
above all.150
Despite Worsoff’s legal advice, which favored protecting the blood
supply and using appropriate screening criteria, the CRCS ultimately
decided to use questionnaires that did not mention AIDS, associated
144. Id.
145. Id. at 74.
146. Id. at 75.
147. Id.
148. KREVER REPORT, supra note 141, at 50–51.
149. PICARD, supra note 62, at 75.
150. Id.
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symptoms, or known risk factors.151  Although doctors implemented
screening measures independent of CRCS, it was not until 1985 that
the CRCS implemented prevention mechanisms, including donor
screening, and changed the questionnaires to “include symptom-
specific questions.”152  Surrogate screening, using Hepatitis B test re-
sults to predict HIV positivity, was never among the measures im-
plemented in Canada.153  By this time, however, HIV had permeated
the blood supply.  HIV seroprevalence was 56% among hemophiliacs
in Montreal; this number increased to 74% by 1988.154  A study of
blood donors in Toronto estimated HIV seropositivity at 0.37%—one
out of every 370 donors may have been infected.155  Because of the
CRCS’s delay in implementing prevention strategies, between 900
and 1400 individuals who received blood transfusions were infected
with HIV.156
The measures implemented by the CRCS in 1985 were less strin-
gent and direct than those adopted in the United States and the
United Kingdom, countries to which the Canadian government refers
for comparative practice.157  Prospective donors were required to read
a pamphlet that provided information about the risk factors and
symptoms of HIV/AIDS. 158  They were then interviewed “to ensure
that they read the information presented to them, were in good
health, had no symptoms of AIDS or HIV infection, and had no rea-
son to be excluded . . . . They were not asked expressly about their
sexual and drug-using activities.”159  These measures in combination
with serological screening implemented in late 1985 have reduced the
risk of transfusion-related transmission of HIV.160
Prior to 1989, “standards of health and safety and of quality as-
surance in the collection, testing, processing, storage, and distribution
of whole blood and its components were in the hands of the operator
151. Id.
152. Id. at 82; see also Gilmore & Sommerville, supra note 73, at 134.
153. Michael Trebilcock et al., Do Institutions Matter?  A Comparative Pathology of the
HIV-Infected Blood Tragedy, 82 VA. L. REV. 1407, 1446 (1996).
154. Gilmore & Sommerville, supra note 73, at 132; see also Kate Dunn, HIV and Canada’s
Hemophiliacs: Looking Back at a Tragedy, 148 CAN. MED. ASSOC. J. 609 (1993).
155. Gilmore & Sommerville, supra note 73, at 133.
156. Id. at 141.
157. Id. at 134–35.
158. Id. at 135.
159. Id.
160. Id.
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of the blood system,” the CRCS.161  In 1989, however, the Canadian
government brought blood and its components under the jurisdiction
of the Food and Drugs Act (FD Act) by labeling blood a Schedule D
substance.162  Despite the incorporation of blood into Schedule D,
regulations that had been in place since 1978 governing “human
plasma collected by plasmapheresis” in Division 4 of the FD Act were
not extended to cover whole blood.163  Currently, “there are . . . no
regulations that relate only to the collection, processing, and distribu-
tion of whole blood or . . . plasma.”164  Whole blood products and
plasma are subject only to the general requirements applicable to
Schedule D substances and “drugs manufactured from ‘preparations
from human sources.’”165  Schedule D regulations require that raw
material (blood) and the ultimate blood to be transfused be tested as
specified, and be subject to “manufacturing and quality control; the
institution of rapid recall procedures; and the maintenance of com-
prehensive records.”166
Even as blood was brought under the jurisdiction of the FD Act
in 1989, Canada lacked a national blood policy, and previous efforts
to institute a national policy had been abandoned.167  The position of
the Red Cross in the Canadian blood system was ill defined, as were
the relationships between the CRCS and the provincial governments,
which contracted with the CRCS for blood service.168  In 1991 the Ca-
nadian Blood Committee (CBC), which coordinated, monitored,
evaluated, and administered the funding for the blood system on be-
half of provincial and territorial governments, was replaced by the
161. KREVER REPORT, supra note 141, at 116.  Schedule D status referred explicitly to
blood derivatives or products created with or from plasma, as opposed to whole blood or blood
components.  Id. at 146.
162. Id. at 129.
163. Id. at 130.  The requirements promulgated in Division Four on plasmapheresis carefully
prescribe all aspects of the donation process, including donor eligibility requirements.  Food and
Drugs Act, C.R.C., ch. 870, §§ 04.404, 04.406 (2001) (Can.).  Plasmapheresis is a process in
which whole blood is taken from a donor through a cell separator.  After the plasma is extracted
from the blood donation by a centrifuge, the donor’s heme is reinjected.  Trebilcock et al., supra
note 153, at 1421.
164. KREVER REPORT, supra note 141, at 132.
165. Id.
166. Id. at 147.
167. 3 THE HONORABLE MR. JUSTICE HORACE KREVER, FINAL REPORT, COMMISSION OF
INQUIRY ON THE BLOOD SYSTEM IN CANADA 1002 (1997) [hereinafter 3 KREVER REPORT].
168. Id. at 1003.
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Canadian Blood Agency (CBA).169  The CBA, a non-profit corpora-
tion, administers and oversees the Canadian blood program.
All of these changes in the institutional structure of the Canadian
blood program were accompanied reluctantly by changes within the
CRCS; standard operating procedures were developed and imple-
mented for the recruitment of blood donors and manufacturing prac-
tices.170  These changes might have been initiated in part in response
to a U.S. FDA inspector’s determination that “operation of the
CRCS Toronto blood center fell short of [U.S.] FDA standards on
nineteen counts [including] the failure to conduct complete searches
for possible sources of HIV infection.”171  CRCS facilities sought to
comply with U.S. FDA standards in order to be eligible to export Ca-
nadian manufactured blood products to the United States.172 Despite
the CRCS’s reorganization, in 1997, the Canadian Ministers of Health
decided “that the Red Cross [CRCS] should no longer have a role in
Canada’s blood system.”173  The decision was based ultimately on the
fact that the “Red Cross’s necessary adherence to the principles of
the international Red Cross movement prevented it from subordi-
nating itself to government policy and direction.”174
The Canadian donor self-exclusion questionnaire currently in
use, the Record of Donation Questionnaire, adopts a conservative
approach to constructing exclusionary criteria.  Canada, like the
United States, proscribes blood donation by individuals who have
lived for six months or longer in the United Kingdom and in France,
and proscribes donations by injection drug users, individuals from
high endemic areas, individuals who have taken clotting factor con-
centrate for hemophilia or other blood disorders, and by men who
have had “sex with a man, even once since 1977.” 175  The Record of
Donation Questionnaire also has several questions targeting female
sexual practices that increase risk of infection.  For example, females
are prohibited from donating blood if they have had sex with men
who have had sex with other men since 1977, or have had sex with an
169. Id. at 1004; see also Trebilcock et al., supra note 153, at 1426.
170. 3 KREVER REPORT, supra note 167, at 1005.
171. Trebilcock et al., supra note 153, at 1449.
172. U.S. federal regulations require that foreign entities seeking to export blood products
to the United States comply with U.S. standards.  See 21 C.F.R. § 607.40 (2000).
173. 3 KREVER REPORT, supra note 167, at 1021.
174. Id.
175. Record of Donation Questionnaire, available at http://www.bloodservices.ca/Centre
Apps/Internet/UW_V502_MainEngine.nsf/9749ca80b75a038585256aa20060d703/ef7f6ef3dabf8d
2785256ab9005caa3c?OpenDocument (last updated Sept. 26, 2001).
HOCHBERG_FMT.DOC 01/24/02  9:25 AM
258 DUKE JOURNAL OF COMPARATIVE & INTERNATIONAL LAW [Vol 12:231
injection drug user, or an individual from a high endemic area.176
These exclusionary criteria are tailored to the epidemiology of HIV
transmission in Canada: 72% of all reported AIDS cases as of De-
cember 1998 were caused by homosexual infection.177  Seventy-seven
percent (77%) of HIV infections in men were caused by homosexual
or bisexual transmission, while 4% were caused by injection drug use
and 3% were caused by blood transfusions.  Of HIV infections in
women, 63% of cases were caused by heterosexual contact, 20% were
caused by injection drug use, and 11% by blood transfusions.178  By
drafting exclusionary criteria that target the risk factors for HIV in-
fections, the Canadian blood system effectively has reduced the risk
of transfusion-transmitted HIV infection.
C. Denmark
Doctors in Denmark were aware as early as 1982 that AIDS
could be transmitted by blood transfusion.179  Because of the central-
ized nature of the health care administration and delivery system in
Denmark, preventative measures were initiated and implemented
quickly to minimize the risk of HIV/AIDS transmission.180
Denmark, like most European Union countries, recognizes a
right to health and health care, derived from both historical national
practice and international law.181  Since 1892, Denmark has provided
176. Id.
177. JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS & WORLD HEALTH
ORGANIZATION, EPIDEMIOLOGICAL FACT SHEET ON HIV/AIDS AND SEXUALLY
TRANSMITTED INFECTIONS, 2000 UPDATE, CANADA, at 6 (2000), available at http://www.
unaids.org/hivaidsinfo/statistics/june00/fact_sheets/pdfs/canada.pdf (last visited Oct. 5, 2001).
178. Id.
179. Erik Albæk, The Never-Ending Story? The Political and Legal Controversies over HIV
and the Blood Supply in Denmark, in BLOOD FEUDS: AIDS, BLOOD, AND THE POLITICS OF
MEDICAL DISASTER 162, 164 (Eric A. Feldman & Ronald Bayer eds., 1999).
180. Jason B. Saunders, Note, International Health Care: Will the United States Ever Adopt
Health Care For All?  A Comparison Between Proposed United States Approaches to Health
Care and the Single-Source Financing Systems of Denmark and the Netherlands, 18 SUFFOLK
TRANSNAT’L L. REV. 711, 716 (1995).
181. Several treaties recognize a general right to health.  See generally U.N. CHARTER, art.
55; CONST. OF THE WORLD HEALTH ORG., opened for signature July 22, 1946, pmbl., 14
U.N.T.S. 185, 186; International Covenant on Economic, Social, and Cultural Rights, Sept. 19,
1966, art. 12, 993 U.N.T.S 3, 8; Convention on the Rights of the Child, Sept. 2, 1990, art. 24, 1577
U.N.T.S. 3, 10.  The Universal Declaration of Human Rights contains some of the strongest lan-
guage expressing a right to health.
Everyone has the right to a standard of living adequate for the health and well-being of
himself and of his family, including food, clothing, housing and medical care and neces-
sary social services, and the right to security in the event of unemployment, sickness,
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compulsory sickness insurance to citizens; by 1960, 75% of the Danish
population was covered under national health insurance policy.182  In
1971, Denmark abolished independent service health care providers,
consolidating insurance in a single national provider system.  This re-
form “allowed municipal authorities to take over the administration
of the system, which provided automatic membership for all inhabi-
tants financed through a graduated tax system.”183
In July 1983, the NBH officially recommended that men who en-
gage in sexual activity with other men, or who identify themselves as
homosexuals, not donate blood.184  This recommendation was revised
in September 1983; NBH requested that “people in high-risk groups
and their sexual partners exclude themselves as donors.”185  The lim-
ited pre-donation screening was supplemented by blood donation
screening for hepatitis B, as a surrogate marker for AIDS.186  In 1985,
NBH implemented measures requiring donors to read an AIDS in-
formation pamphlet and to sign a statement that they did not belong
to any of the enumerated risk groups.187
Prior to 1985, only one case was reported of an HIV-positive in-
dividual donating blood in Denmark.  The donor was a self-identified
homosexual man who gave blood three times between June 1983 and
May 1984.188  All of the recipients of the infected blood died of pri-
mary diseases.189  However, despite Denmark’s efforts to protect the
disability, widowhood, old age or other lack of livelihood in circumstances beyond his
control.
Universal Declaration of Human Rights, Dec. 10, 1948, art. 25, G.A. Res. 217A(III), U.N. Doc.
A/810, at 71.
182. Saunders, supra note 180, at 716.
183. Id. at 717.
Denmark’s national health care system is divided into nineteen ministries, as well as addi-
tional departments and subspecialty units.  Id. at 726 n.63.  The National Board of Health
(NBH) advises the ministries on health matters.  Id.  This agency’s authority exceeds advisory
status, as it exerts control over subspecialty and policy development.  Id.  Furthermore, its pol-
icy recommendations are compulsory.  Id.
184. Albæk, supra note 179, at 164.
185. Id. at 165.
186. M.P. Busch et al., Value and Cost-Effectiveness of Screening Blood Donors For Anti-
body To Hepatitis B Core Antigen as a Way of Detecting Window-Phase Human Immunodefi-
ciency Virus Type 1 Infections, 37 TRANSFUSION 1003, 1003 (1997) (finding that “the value of
screening donors for antibody to hepatitis B core antigen (anti-HBc)” because of its “low yield
and very poor cost-effectiveness . . . indicates that this test is not an effective screening test for
HIV-1 . . . donations”).
187. Albæk, supra note 179, at 165.
188. Id. at 171.
189. The term primary disease refers to a cause of death independent of HIV, for example
lung cancer or heart failure.
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blood supply from transfusion-related HIV transmission, contami-
nated blood products imported from the United States and other
countries had caused the infection of eighty-nine hemophiliacs.190  A
study published in the British journal The Lancet estimated that 64%
of Danish hemophiliacs were HIV-positive by 1984.191  The prevalence
of HIV among hemophiliacs, as well as reports of blood transfusions
of infected blood, caused widespread discontent with Danish blood
policy. 192  In late 1985, the NBH mandated that HIV antibody
screening of blood donations be implemented as a matter of urgency
starting January 1, 1986.193
Many hemophiliacs, physicians, and activist groups aver that the
NBH should have introduced prevention measures, including
screening and heat treatment of blood products for hemophiliacs,
much earlier than 1986.194  However, despite extensive litigation, the
conduct of NBH and its ministers was not found to have been negli-
gent by Denmark’s High Court or Supreme Court.195  As a result of
the litigation, Denmark and its health system have implemented ex-
tensive measures with respect to the safety of blood and blood prod-
ucts.  Since 1986, all blood, sperm, and organ donors have been
screened.196
Denmark has the highest rates per capita of HIV infection and
AIDS in Scandinavia, and a moderate rate per capita compared to
other European countries.197  UNAIDS estimates that in 1999, 0.17%
of the Danish population, or 4,300 individuals, were living with
HIV/AIDS.198  The measures implemented since 1986 have been suc-
cessful in preventing HIV contamination of the blood supply and
190. Id. at 182.
191. Id. at 166.
192. Id.
193. Id. at 173.
194. Id.
195. See id. at 175–83.  (Cases included Gentofte Kriminalrets dom af 29.11.1989 i sag
443/1988 (Den.); Case of A. and Others v. Denmark, 22 Eur. Ct. H.R. 456 (1996) (60/1995)).
196. Annika Snare, The Legal Treatment of AIDS in Denmark, in AIDS AND HUMAN
RIGHTS: AN INTERNATIONAL PERSPECTIVE 34, 36 (1988).
197. The rates per capita as estimated by Joint United Nations Programme on HIV/AIDS &
World Health Organization are Sweden 0.09%; Norway 0.07%; Netherlands 0.19%; France
0.43%; and Spain 0.58%.
198. JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS & WORLD HEALTH
ORGANIZATION, EPIDEMIOLOGICAL FACT SHEET ON HIV/AIDS AND SEXUALLY
TRANSMITTED INFECTIONS, 2000 UPDATE, DENMARK, at 3 (2000), available at http://www.
unaids.org/hivaidsinfo/statistics/june00/fact_sheets/pdfs/denmark.pdf (last visited Nov. 2, 2001)
[hereinafter Denmark Fact Sheet].
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transfusion-related transmissions.  By 1988, the exclusionary criteria
on the blood donor questionnaire had been expanded to include pro-
hibitions on blood donations by MSM, bisexual men, intravenous
drug users, prostitutes, individuals who have resided in “Africa, India,
South-East Asia or South America,” or individuals who have had in-
tercourse with any people within these categories, or suffered from
various illnesses.199  The use of this questionnaire significantly reduced
the risk of transfusion-related transmission of HIV; by 1988, the
transfusion-related transmission rate was less than one per 400,000.200
The risk of transfusion-related transmission was reduced by use
of the pre-donation questionnaire in combination with HIV screening
because the questionnaire was tailored to the epidemiological situa-
tion in Denmark.201  In Denmark, 66% of men with HIV are infected
through homosexual contact, 19% by heterosexual contact, and 9%
through intravenous drug use.202  Sixty-three percent (63%) of women
are infected by heterosexual contact, 13% of whom are infected by
bisexual men.203  A study conducted during 1986–1988, just after im-
plementation of pre-donation and serological screening programs,
found that out of 1,200,000 donations, only nineteen donors were
HIV-positive.204  Nine of these nineteen donors, or 47%, had risk fac-
tors for HIV infection that should have precluded them from donat-
199. Denmark Blood Donor Questionnaire (Henrik Hensen, trans.), available at http://www.
bloddonor.dk (last visited Nov. 2, 2001).
200. Kirsten W. Schmidt & Ebbe Dickmeiss, Screening af donorblod for anti-HIV. Erfar-
inger fra bloddonorscreeningen 1986–1988 [Screening of donor blood for anti-HIV. Experiences
from blood donor screening 1986–1988], 152 UGESKR LAEGER 2552 (1990) (Den.).  More recent
statistics were not available.
201. The Danish blood donation standards closely resemble “the standards laid down in the
7th edition of the Guidelines [for the selection of blood donors], produced by the Council of
Europe.”  E-mail from Niels Mikkelsen, Secretary General, Blood Donors in Denmark (Mar. 8,
2001, 03:23:28 EST) (on file with the Duke Journal of Comparative and International Law).
Systematic screening of blood donations is practiced in all European Union Member States, and
is required by law in Belgium, France, Germany, Norway, and other countries.  Reviron et al.,
supra note 99, at 25.
202. Else Smith & Mads Melbye, Det førsteårs erfaringer med et indberetningssystem for
HIV-positive i Danmark [First year experience with a system of mandatory reporting of HIV-
positive cases in Denmark], 154 UGESKR LAEGER 2196 (1992) (Den.); see also Denmark Fact
Sheet, supra note 198, at 6 (finding the rates of infection virtually unchanged: among men with
AIDS, 66.2% were infected through homosexual contact, 17.7% through heterosexual contact,
and 8.6% through injection drug use; among women with AIDS, 65.6% were infected through
heterosexual contact, 21.3% through injection drug use, and 2.5% through perinatal transmis-
sion).
203. Denmark Fact Sheet, supra note 198, at 6.
204. Schmidt, supra note 200, at 2552.
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ing.205  Denmark’s pre-donation self-exclusion questionnaire is tai-
lored to screen out individuals who pose a significant risk of transmit-
ting HIV.  As long as individuals self-exclude, the use of this ques-
tionnaire will continue to contribute to the reduced risk of
transfusion-related transmission of HIV in Denmark.
D. Australia
AIDS was first diagnosed in Australia between 1981 and 1982. 206
In Australia, as in Canada, the United States, and Denmark, the dis-
ease initially affected the homosexual population.  By 1984, up to
50% of homosexual men in Sydney were seropositive.207  As is charac-
teristic of a Pattern One country, HIV/AIDS only later spread among
intravenous drug users and then minimally among the heterosexual
population. 208  Of the estimated 14,000 individuals currently living
with HIV/AIDS in Australia, only 900 are women, 19.1% of whom
acquired HIV through transfusions of blood or other blood prod-
ucts.209  Eighty-four percent (84%) of men diagnosed with AIDS
through 1998 were homosexual or bisexual.210  Since 1984–1985, HIV
transmission and incidence have declined overall; even today, new in-
fections continue to be diagnosed predominately among homosexual
and bisexual males.211
Australia has been one of the most proactive of the developed
countries in formulating legislative policies to address HIV/AIDS.
Because Australian regulation occurs on both the provincial and state
level, Australian policies concerning the control and prevention of
HIV transmission and infection have been less uniform than those of
205. Id.
206. John Ballard, HIV-Contaminated Blood and Australian Policy: The Limits of Success,
in BLOOD FEUDS: AIDS, BLOOD, AND THE POLITICS OF MEDICAL DISASTER 244, 244 (Eric A.
Feldman & Ronald Bayer eds., 1999).
207. Geoffrey Walker, Australia’s Response to AIDS: The Law and the Policy Issues, in
LEGAL RESPONSES TO AIDS IN COMPARATIVE PERSPECTIVE 169, 169 (Stanislaw Frankowski
ed., 1998).
208. JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS & WORLD HEALTH
ORGANIZATION, EPIDEMIOLOGICAL FACT SHEET ON HIV/AIDS AND SEXUALLY
TRANSMITTED INFECTIONS, 2000 UPDATE, AUSTRALIA, at 3 (2000), available at http://www.
unaids.org/hivaidsinfo/statistics/june00/fact_sheets/pdfs/australia.pdf.  (last visited Oct. 10,
2001).
209. Id. at 3.
210. Id. at 6.
211. Walker, supra note 207, at 170.
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other countries, notably the United Kingdom.212  Australia is a Com-
monwealth comprised of states and territories.  Thus, while a “Com-
monwealth statute . . . creates uniform law on its respective subject
matter throughout Australia . . . the Commonwealth has had only
limited involvement in public health law and a great deal of the rele-
vant regulation exists at the State and Territory level.”213  The division
of legislative oversight “between the Commonwealth, States and Ter-
ritories has been identified as a major barrier to achieving ‘best prac-
tice’ health care.”214  Despite this division, there has been “a substan-
tial amount of cooperation and collaboration between State and
Commonwealth health officials” on HIV and related issues.215  The
cooperation between state and Commonwealth governments and the
resulting rapid legislative action addressing HIV/AIDS is due in part
to the fact that the government was largely responsible for managing
and maintaining the blood supply in the 1980s.216  The Australian
Blood Transfusion Services (ABTS) was operated under the auspices
of the Australian Red Cross Society, but was coordinated and main-
tained by the National Blood Transfusion Committee (NBTC).217
Subsequent to 1976, Australian federal and state governments shared
the capital costs of ABTS: “operating costs were met 60% by state
governments, with the Red Cross contributing the lesser of 5% of
costs . . . and the balance covered by the federal government.”218  The
Commonwealth or federal government is involved in health care fi-
nance, but the primary responsibility for providing health services in
Australia rests with the six state and two territorial governments.219
Thus, when the threat of HIV was found in the Australian blood sup-
ply and in Australian-manufactured blood products, the state gov-
ernments quickly took action, testing blood and implementing pre-
vention protocols.220
212. Marlene C. McGuirl & Robert N. Gee, AIDS: An Overview of the British, Australian,
and American Responses, 14 HOFSTRA L. REV. 107, 113 (1985).
213. Brian R. Opeskin, The Architecture of Public Health Law Reform: Harmonisation of
Law in a Federal System, 22 MELB. U. L. REV. 337, 338 (1998).
214. Id.
215. McGuirl & Gee, supra note 212, at 113.
216. Ballard, supra note 206, at 244.
217. Id. at 245.
218. Id. at 246.
219. Id.
220. Id. at 244.  The first documented case of transfusion transmitted HIV was reported in
July 1984.  See id. at 250.
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In May 1983, Dr. Gordon Archer, director of the Sydney Blood
Transfusion Services, “called publicly for homosexual men to avoid
donation.”221  Archer’s statement was the first public announcement
identifying high risk groups in Australia and was met with protest
from homosexual interest groups in Sydney.222  However, Archer’s
recommendation was not unfounded; seroprevalence among homo-
sexual men in Sydney had reached 50%.223  Through 1997, the major-
ity of HIV cases in Australia had occurred amongst homosexual and
bisexual men, accounting for 80.3% of infections; another 3.1% of in-
fected homosexual and bisexual men have intravenous drug use as a
possible risk factor.224  Because NBTC concluded that Archer’s rec-
ommendations were justified by the epidemiology of HIV transmis-
sion in Australia, it began to take steps towards creating a formal
screening questionnaire in the form of “information sheets with simi-
lar wording . . . issued at donation centers asking for abstention by
sexually active homosexual or bisexual men with multiple partners,
intravenous drug users, and sexual partners of these people.”225
Rather than adopting a national protocol, however, each state’s blood
transfusion services (BTS) accepted responsibility for implementing
its own preventative measures.226  None of the BTS at that time “pro-
ceeded to introduce screening measures beyond the distribution of
pamphlets to donors, relying on voluntary self-exclusion.”227  The de-
lay in implementation among the state BTS was due partly to pres-
sure from gay activists who alleged that the proposed measures were
discriminatory. 228  The delay in implementation, however, adversely
affected blood supply protection: in the early 1980s, Australia had a
rate of transfusion-transmitted HIV/AIDS up to five times higher
than that of the United States.229
In July 1984, the first case of transfusion-transmitted HIV was
reported in Australia.230  Almost immediately more stringent meas-
ures were implemented to protect blood supplies from HIV and other
221. Id. at 249.
222. Id.
223. Walker, supra note 207, at 169.
224. Id. at 169–70.
225. Ballard, supra note 206, at 249.  In Victoria, the inclusion of the qualifier multiple part-
ners led to litigation.
226. Id.
227. Id. at 250.
228. Id.
229. Walker, supra note 207, at 172.  The actual numbers are not available.
230. Ballard, supra note 206, at 250.
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virus contamination.  The Sydney BTS mandated that donors sign a
form declaring that “they were not a member of a high-risk group.” 231
Hepatitis B testing also was begun as a surrogate test for HIV, though
this later was found to be ineffective.232  At this time, few other states
in Australia had adopted measures as extensive as those adopted in
Sydney, although the categories of donors precluded from blood do-
nation had been expanded.233
Three more cases of transfusion-transmitted HIV were reported
in Queensland in mid-November 1984.  All three of the cases in-
volved infants who died after receiving infected blood donated by an
HIV-positive homosexual.234  The Queensland government responded
by passing legislation that imposed “criminal sanctions for false decla-
rations by [blood] donors.”235  In reaction to this action by the Queen-
sland government, the Australian Commonwealth Minister of Health
decided to create a uniform national policy on blood donation so as to
coordinate the various state practices.236
The policy measures adopted in Australia are enforced by crimi-
nal law.  Legislation has been enacted that renders “false or mislead-
ing declarations by blood donors an offense punishable by fine or im-
prisonment.”237  Blood will not be accepted from blood donors unless
they sign a statement concerning their involvement in “high risk” ac-
tivities.238  This legislation and other preventative measures adopted in
231. Id.
232. Id. at 251 n.21.  Dr. Ian Gust tested sera from 601 people who had tested positive to
hepatitis B core antigen and found no evidence of HIV infection.
233. Id. at 251.
234. Id. at 252.
235. Id.; see also Walker, supra note 207, at 207.  Although such legislation initially was
widely criticized, it has gained increasing acceptance.  In the United States, for example, be-
tween 1987 and 1989, twenty states enacted legislation criminalizing behaviors which constituted
a significant risk for transmitting HIV.
236. Ballard, supra note 206, at 252.
237. Id. at 253–54. (“Although several HIV-positive donors were found to be aware of their
risk status, there were no prosecutions [under the Australian legislation] until a case arose in
1993 in Victoria, leading to conviction, in which there was public evidence that the donor was
aware of being HIV-positive.”).
238. See Human Tissue Act, 1983 (N.S.W.), as amended by Regulation No. 308 of 1986
(N.S.W.), reprinted in WORLD HEALTH ORGANIZATION, LEGISLATIVE RESPONSES TO AIDS
4–6 (1989).  Form 3 (§ 21 c) states, “There are some people in the community who MUST NOT
donate blood because their blood may transmit infection to patients who receive it.  Prostitutes
should not donate blood.  The following certificate must be completed and signed by any person
who wishes to donate blood.  Please read it carefully as it is an offence knowingly to sign a cer-
tificate which contains any statement which is false or misleading and any person who does so is
liable to a heavy penalty.”  Id.  Included among the statements on the certificate is the follow-
ing: “3. I have not engaged in male to male sexual activity since 1980.”  Id.; see also WORLD
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Australia, such as the extensive pre-donation donor exclusion ques-
tionnaire, have proven highly effective in preventing transfusion-
related transmission of HIV. 239  From April 1985 to December 1996,
“out of 11 million blood donations tested for HIV-1-antibody, [only]
87 were found to be positive.”240  The effectiveness of these measures
is due in large part to the fact that the questionnaires are tailored to
Australia’s epidemiological situation.  The known residual risk of ac-
quiring HIV through a blood transfusion in Australia is 7.9 x 10-6 (7.9
per million),241 substantially less than the risk in the United States, in
1991, of less than 20 per million.242  Since 1985, there have been no re-
ported instances of transfusion associated HIV in Australia.243
E. Uganda
Uganda was one of the first sub-Saharan African countries in
which AIDS was reported,244 and also has been one of the countries
hardest hit by the epidemic.245  Because of the large numbers of deaths
due to HIV/AIDS, “demographers project that [by the year 2010] life
expectancy will fall from . . . 59 to 31 years in Uganda.”246
Although HIV/AIDS has taken a substantial social and economic
toll on Uganda, Uganda “has been sited [sic] as the success story in
Sub-Saharan Africa in its efforts to reduce HIV prevalence levels.”247
HEALTH ORGANIZATION, LEGISLATIVE RESPONSES TO AIDS 4–5 (1989) (reprinting Austra-
lian Capital Territory and province legislation concerning blood donation).
239. See Mary-Louise McLaws & Jennifer Learmont, Heterosexually Acquired HIV Infec-
tion in Female Blood Donors: Case Series Between 1985–1990, 7 AIDS CARE 631 (1995).
240. Ballard, supra note 206, at 253.  For a discussion of HIV-1 see infra note 252.
241. See Gordon S. Whyte & Helen F. Savoia, The Risk of Transmitting HCV, HBV, or HIV
By Blood Transfusion in Victoria, 167 MED. J. AUSTL. 142, 142, 146 (1997).
242. Fiebig, supra note 43, at 6, 14.  The residual risk is estimated to be at least five to ten
times lower than the rate in similar developed countries.  Ballard, supra note 216, at 262.  The
only negative consequence of the extensive pre-donation interviews and consequent donor re-
jections has been the 25% decline in blood collection since 1984.  Id. at 262–63.  Australia has
dealt with the decline in blood donations by reorganizing the blood system and reduction in
consumption of blood products.  Id. at 263.
243. Id. at 254.
244. NATIONAL RESEARCH COUNCIL, supra note 10, at 48.
245. Id. at 233; see also Ian M. Timæus, Impact of the HIV Epidemic on Mortality in sub-
Saharan Africa: Evidence from National Surveys and Censuses, 12 AIDS S21–22 (Supp. 1 1998)
(“In just 6 years in Uganda, men’s death rates nearly doubled and women’s death rate more
than doubled.  The probability of dying between ages of 15 and 60 rose from a moderate level to
one of the highest levels documented in Africa since the 1960s.”).
246. NATIONAL RESEARCH COUNCIL, supra note 10, at 2.
247. JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS & WORLD HEALTH
ORGANIZATION, EPIDEMIOLOGICAL FACT SHEET ON HIV/AIDS AND SEXUALLY
TRANSMITTED INFECTIONS, 2000 UPDATE, UGANDA, at 3 (2000), available at http://www.
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Uganda was one of the first African countries to acknowledge pub-
licly HIV/AIDS and the extent to which it was impacting the country
and to invite foreign assistance to improve the general health system
and implement programs to address the epidemic.248  Unlike many
HIV/AIDS interventions in other sub-Saharan countries, such as
Kenya, Zambia, and Zimbabwe, Ugandan HIV/AIDS interventions
have had a significant impact.249  In the late 1980s, HIV seropreva-
lence was 15–20%;250 in 1999, the HIV seroprevalence among adults
was 8.3%.251  This decline in seroprevalence is due in part to mortality
and to reduced rates of new infections, and in part to HIV/AIDS in-
tervention policies.  The impact of HIV/AIDS interventions is also
evidenced by the “recent reduction in the prevalence of HIV-1 infec-
tion among young males in rural Uganda,”252 and a fall in infant and
child mortality in the early 1990s.253
unaids.org/hivaidsinfo/statistics/june00/fact_sheets/pdfs/uganda.pdf (last visited Oct. 3, 2001)
[hereinafter Uganda Fact Sheet].
248. EUROPEAN COMMISSION, DEVELOPMENT: STUDIES AND RESEARCH, SAFE BLOOD IN
DEVELOPING COUNTRIES: LESSONS FROM UGANDA 50 (Rex Winsbury ed., 1995) [hereinafter
LESSONS FROM UGANDA].
249. Compare HIV prevalence among antenatal women in four countries’ urban and rural
areas: In Kenya, HIV prevalence among antenatal women in one urban area increased from 2%
in 1985 to 19% in 1995.  In rural areas, it increased from less than 1% to 13% in 1997.  JOINT
UNITED NATIONS PROGRAMME ON HIV/AIDS & WORLD HEALTH ORGANIZATION,
EPIDEMIOLOGICAL FACT SHEET ON HIV/AIDS AND SEXUALLY TRANSMITTED INFECTIONS,
2000 UPDATE, KENYA, at 3 (2000), available at http://www.unaids.org/hivaidsinfo/statistics/
june00/fact_sheets/pdfs/kenya.pdf (last visited Oct. 3, 2001).  In Zambia, HIV prevalence had
increased from 5% in 1985 to 27% in 1992 and it has since remained stable at that rate.  JOINT
UNITED NATIONS PROGRAMME ON HIV/AIDS & WORLD HEALTH ORGANIZATION,
EPIDEMIOLOGICAL FACT SHEET ON HIV/AIDS AND SEXUALLY TRANSMITTED INFECTIONS,
2000 UPDATE, ZAMBIA, at 3 (2000), available at http://www.unaids.org/hivaidsinfo/statistics/
june00/fact_sheets/pdfs/zambia.pdf (last visited Oct. 3, 2001).  In Zimbabwe, HIV prevalence
increased from 10% in 1989 to 36% in 1994.  JOINT UNITED NATIONS PROGRAMME ON
HIV/AIDS & WORLD HEALTH ORGANIZATION, EPIDEMIOLOGICAL FACT SHEET ON
HIV/AIDS AND SEXUALLY TRANSMITTED INFECTIONS, 2000 UPDATE, ZIMBABWE, at 3
(2000), available at http://www.unaids.org/hivaidsinfo/statistics/june00/fact_sheets/pdfs/
zimbabwe.pdf (last visited Oct. 3, 2001).  In urban areas in Uganda, by comparison, HIV
prevalence increased from 11% in 1985 to 31% in 1990, but then declined to 14% by 1998.  In
rural areas, HIV prevalence was 13% in 1992; it declined to 8% by 1998.  Uganda Fact Sheet,
supra note 247, at 3.
250. Uganda Fact Sheet, supra note 247, at 3.
251. Id.
252. NATIONAL RESEARCH COUNCIL, supra note 10, at 45.  HIV-1 refers to the first strain
of HIV independently isolated by Dr. Luc Montagnier and isolated and propagated by Dr.
Robert Gallo.  See SCHOUB, supra note 19, at 9–10.  HIV-2 was isolated in 1986 by Dr. Montag-
nier and his colleagues from AIDS patients in Guinea Bissau and the Cape Verde Islands.  Id. at
11.
253. Timæus, supra note 245, at S20.
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The HIV/AIDS interventions undertaken by the Ugandan gov-
ernment have succeeded because of legal reform as well as reforms in
health policy and delivery.254  This approach is stated explicitly in the
government’s multisectoral policy on HIV/AIDS:
All Ugandans have individual and collective responsibility to be ac-
tively involved in AIDS control activities in a coordinated way.
The fight against AIDS is not only directed at the prevention of the
spread of HIV, but also addresses the active response to, and man-
agement of, all perceived consequences of the epidemic.255
The Ugandan non-discrimination policies have not eliminated indi-
vidual discrimination against, and stigmatization of, individuals with
HIV/AIDS.256  The policies nonetheless demonstrate Uganda’s com-
mitment to caring for individuals with HIV/AIDS and preventing fur-
ther spread of the virus.257
Among the most successful of the prevention policies imple-
mented by the Ugandan government, with the assistance of foreign
non-governmental organizations, has been the reorganization of the
Uganda Blood Transfusion Service (UBTS).  The UBTS “has been
one of the major instruments of AIDS control in the country, rivaling
if not exceeding in influence other . . . AIDS prevention strategies.”258
In 1987, Lorenzo Natali, then vice-president of the European
Commission, issued a memorandum to certain African, Caribbean,
and Pacific countries.259  Natali’s memorandum offered direct aid from
the European Commission (EC) to countries to design and imple-
ment AIDS interventions and preventions.260  Uganda affirmatively
responded to the EC’s offer, and after extensive discussion with the
Ugandan government, Dr. Lieve Fransen, an EC consultant, recom-
mended that “EC support to Uganda could best be used for a safe
blood initiative.”261  The program not only would prevent further
spread of HIV/AIDS, but also would improve the quality of health
care provided.  Although HIV was transmitted predominately by het-
254. LESSONS FROM UGANDA, supra note 248, at 50–53.
255. UNAIDS, HIV AND AIDS—RELATED STIGMATIZATION, DISCRIMINATION, AND
DENIAL: FORMS, CONTEXTS, AND DETERMINANTS: RESEARCH STUDIES FROM UGANDA AND
INDIA 28 (2000), UNAIDS/00.16E (English Original, June 2000).
256. Id. at 28–30.
257. See id. at 34.
258. LESSONS FROM UGANDA, supra note 248, at 28.
259. Countries that received EC development funds were signatories to the Second Lomé
Convention.  Second ACP-EC Convention of Lomé, opened for signature Oct. 31, 1979, 1980
O.J. (L347) 2, 19 I.L.M. 327.
260. Id. at 59.
261. Id. at 34.
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erosexual activity in Uganda, accounting for up to 80% of infections,
a significant number of the remaining cases were caused by blood
transfusions.262  These cases were preventable and afflicted individu-
als, especially children, who might not otherwise have become in-
fected.
The needs for and uses of blood in most African countries differ
widely from those in Europe and North America.  In the latter, blood
is used primarily for emergency operations or other post-traumatic
events,263 whereas in developing countries blood often is used to treat
anemia.  For example, at one hospital in Kinshasa, Zaire,264 87% of
blood transfusions were given to children for malaria-induced ane-
mia.265  Furthermore, in many sub-Saharan African countries, like
Uganda, “both the need and the circumstances are different, with
children and maternity cases being the main recipients, and electricity
supplies often unreliable.”266  Dr. Fransen thus advised:
For several reasons the importance of transfusion as a mode of
transmitting HIV infection is much greater in Uganda than in most
industrialised countries.  First, the seroprevalence of HIV infection
in the general population is very high, transfusions are given much
more frequently in Uganda than in industrialised countries, and
more than 50 per cent of the transfusions go to children with ma-
laria. . . . The prevention of this mode of transmission is technologi-
cally feasible and the high rate of seropositivity among blood do-
nors makes this intervention more cost-effective than in Europe.  In
addition, the improved medical use of blood transfusions, and the
greater availability of properly stored and screened blood, will have
a positive effect on health and health systems in general.267
Fransen’s ultimate recommendation was that the EC sponsor the re-
habilitation of blood transfusion facilities in Kampala.268  After the
creation of adequate facilities and the reorganization of the UBTS,
262. Id. at 60; see also R.D. Mugerwa et al., Human Immunodeficiency Virus and AIDS in
Uganda, 73 E. AFR. MED. J. 20 (1996).
263. LESSONS FROM UGANDA, supra note 248, at 37.
264. On May 16, 1997, the name of Zaire was formerly changed to the Democratic Republic
of the Congo.  Because UNAIDS has not adopted this change, for the sake of consistency, the
Democratic Republic of the Congo will be referred to as Zaire in this note.  CENTRAL
INTELLIGENCE AGENCY, THE WORLD FACTBOOK 111 (1999).
265. NATIONAL RESEARCH COUNCIL, supra note 10, at 97.
266. LESSONS FROM UGANDA, supra note 248, at 37.
267. Id. at 60–61.  At the time, the rate of HIV seroprevalence in the general population was
15–20%.  Id.
268. Id. at 61.
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safe blood could be supplied to Kampala and surrounding areas, and
then eventually to other regions of the country.269
In 1986, “9% of all blood donated at the main Mulago teaching
hospital in Kampala was positive for HIV.”270  At this time, mission
hospitals, notably Nsambya and the new Mulago hospital, imple-
mented limited testing of blood donations.271  These facilities were
funded both by the EC and the WHO.  However because “HIV test-
ing was not available for the majority of hospitals in other towns in
Uganda,” the testing had limited impact on reducing the transmission
of HIV by transfusion.272  Furthermore, few other preventative meas-
ures had been implemented fully.
The reorganization of the UBTS began with infrastructural de-
velopment, specifically the rehabilitation of the former Kampala
blood bank in Nakasero (NBB).  By 1988, while the rehabilitation
was underway, the Ugandan Red Cross had become ineffective
largely because of a decline in funding and support from the middle
class and business communities.273  NBB thus had to develop its own
donor recruitment program.  The Ugandan Red Cross lent its name
and authority to the NBB program.274  In 1990, the blood bank facili-
ties were completed and NBB had initiated its program to recruit safe
blood donors. 275
NBB requires that blood donor recruitment be limited to volun-
tary, altruistic blood donation.276  Donor recruitment focuses on sec-
ondary school and college students because of the epidemiology of
HIV infection in Uganda: HIV prevalence is highest in both urban
and rural populations in Uganda among 25 to 44 year old males, and
15 to 34 year old females.277  Once prospective donors are recruited,
they are given pre-donation counseling.  This counseling consists of
giving potential donors “facts concerning the need for blood transfu-




273. Id. at 64.
274. Id. at 64–65.
275. Id. at 78.
276. Id. at 69, 113.
277. NATIONAL RESEARCH COUNCIL, supra note 10, at 76 (citing D. Serwadda et al., HIV
Risk Factors in Three Geographic Strata of Rural Rakai District, Uganda, 6 AIDS 983–89
(1992)); Hans-Ulrich Wagner et al., General and HIV-1 Associated Morbidity in a Rural Ugan-
dan Community, 7 AIDS 1461, 1463 (1993).
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sion and the reasons why people should give blood to save lives.” 278
The counseling is designed to facilitate a potential donor’s identifica-
tion of his or her own risk factors and aid the donor in deciding
whether to self-defer.
By 1989, seroprevalence among donated blood in Uganda had
risen to 24%; thus demand for the screened blood from NBB rapidly
increased.279  Within a year of opening, the majority of local hospitals
and blood collection services sent blood to be processed at NBB.280
NBB’s decision to provide blood bank services to all hospitals was the
first step towards formation of a national blood bank.281  In 1990,
NBB’s safe blood project was extended to the rest of Uganda.282  In
addition to creating regional blood banks, a plan to provide HIV
testing was initiated and implemented in conjunction with NBB.283
Since national testing started in 1990, 200,000 individuals have been
tested.284  The widespread implementation of HIV testing has reduced
the number of infected individuals donating blood; this protects the
blood supply, since people no longer need to resort to blood donation
as a means by which to ascertain their HIV status.
A 1995 report on UBTS estimates that in 1994 alone, 7,200 peo-
ple would have been infected with HIV by blood transfusions in
Uganda had the UBTS protocols not been implemented.285  Other
benefits include that about 60,000 people each year attend talks given
by UBTS recruitment officers, thus gaining invaluable education
about HIV/AIDS and the infection’s transmission. 286  Furthermore,
over 75,000 HIV tests are administered per year, increasing aware-
ness and potentially further reducing transmission rates.287
The Blood Donation Questionnaire administered by the UBTS
differs greatly from those administered in the United States, Canada,
Denmark, and Australia.  It is extremely short, proscribing donation
if a donor affirms the following statements:
In the last six months you have had sex with someone you are un-
sure about.
278. LESSONS FROM UGANDA, supra note 248, at 113.
279. Id. at 48.
280. Id. at 63.
281. Id.
282. Id. at 79.
283. Id.
284. Id. at 84.
285. Id. at 92.
286. LESSONS FROM UGANDA, supra note 248, at 93.
287. Id.
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In the last two months you have had an illness such as a bad cold.
In the last year you have had:
i. An injection except at a hospital or clinic; or
ii. Skin scarring or cutting by a traditional healer; or
iii. A surgical operation.
You have ever had hepatitis (jaundice causing yellow coloration of
the eyes).288
The self-exclusion questionnaire does not address explicitly the epi-
demiology of sexual HIV transmission in Uganda, although it does
address the increased risk of infection associated with injections and
transfusions.289  In Uganda, the strongest risk factor for HIV incidence
is the number of sexual partners an individual has had in his or her
lifetime.  Both men and women who report five or more sexual part-
ners have a significantly higher risk of HIV infection than those who
report at most one partner.290  Men and women who are unmarried
and in “steady” relationships have a higher risk of infection than do
those who are married.291  Similarly, men who are divorced, separated,
or widowed have a higher risk of infection than do those who are
married.292  The Ugandan blood donation questionnaire does not
question donors about these activities, instead asking only whether
the potential donor has had sex with someone he or she in unsure
about.
The donor self-exclusion questionnaire is not sufficiently nar-
rowly tailored to address specific forms of sexual transmission of
HIV, but rather is drafted broadly to encompass any sexual contact in
which the partner is “unsure” about the other partner’s HIV status.
This pre-donation donor exclusion likely has contributed to the re-
duction in transfusion-associated HIV in Uganda resulting from se-
rological screening of donated blood.  No studies have been done in
Uganda on this point, however, and there is no information available
on current levels of transfusion-transmitted infection.  Research has
shown that behavioral risk factor screening through donor self-
exclusion questionnaires effectively contributes to a reduction in the
288. Uganda Blood Donation Questionnaire (on file with the Duke Journal of Comparative
and International Law).
289. Id.
290. Maria A. Quigley et al., Case-Control Study of Risk Factors for Incident HIV Infection
in Rural Uganda, 23 J. ACQUIRED IMMUNE DEFICIENCY SYNDROME 418, 422 (2000).
291. Id. at 420.
292. Id.
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risk of transfusion-related transmission of HIV.293  Implementation of
a more narrowly tailored questionnaire by the UBTS likely would
contribute to a further decline in the incidence of transfusion-related
HIV infections.
F. Singapore
Singapore became a fully independent state in 1965 when it sepa-
rated from the Malaysian federation formed in 1959 at the end of
British colonial rule.294  Singapore, though still a considered a devel-
oping country, has the world’s largest trade surplus per capita and is
the eleventh largest trading partner of the United States.295  Credit for
much of Singapore’s rapid economic development has been given to
its system of governance.  Singapore’s government exercises extensive
control over traditional areas of government regulation as well as
over the country’s economy.296  Known as “soft authoritarianism” or
“Confucian capitalism,” the Singaporean political system embodies
the
concept of a government by honourable men (junzi), who have a
duty to do right for the people, and who have the trust and respect
of the population. [This concept directly contradicts the] Western
idea that a government should be given as limited powers as possi-
ble, and should always be treated with suspicion unless proven oth-
erwise.297
The government justifies its extensive legislative and economic regu-
latory powers as furthering a “communitarian adaptation of free
market economics.”298
293. See supra text accompanying note 39; see also Yupa Urwijitaroon et al., Reducing the
Risk of HIV Transmission Through Blood Transfusion By Donor Self-Deferral, 27 SE. ASIA J.
TROPICAL MED. & PUB. HEALTH 452 (1996).  A self-deferral form was given to all blood do-
nors that included “questions about HIV risk factors in the three month period prior to blood
donation.”  Among general donors, the prevalence of anti-HIV antibodies was 0.61%, while
among self-deferred high risk donors, it was 1.99%.  “In comparison with the general donors,
the high risk donors demonstrated statistically significant higher prevalence rates of HIV anti-
gen (p <0.05. . .).”
294. Rafael X. Zahralddin-Aravena, Chile and Singapore: The Individual and the Collective,
a Comparison, 12 EMORY INT’L L. REV. 739, 767 (1998).
295. Id.
296. Douglas L. Tookey, Singapore’s Environmental Management System: Strengths and
Weaknesses and Recommendations for the Years Ahead, 23 WM. & MARY ENVTL. L. & POL.
REV. 169, 175 (1998).
297. Li-ann, supra note 1, at 73 (quoting Shared Values White Paper, ¶ 41, (Cmd 1, 1991)
(Sing.)).
298. Zahralddin-Aravena, supra note 294, at 741–42.
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Singapore’s health regulations are based on the Constitutional
premise that “individual concerns must sometimes be subordinated to
collective interests.”299  Part IV of the Singapore Constitution recog-
nizes the “Individual as the primary normative unit which the state is
supposed to serve.”300  Individual rights, however, are not absolute:
constitutionally defined individual “liberties are subject to derogating
laws relating to such collective interests as ‘public order, public
health, or morality’.”301
The Singaporean health system, including the public health sys-
tem, is highly regulated. Three different governmental Ministries, as
well as the private sector, administer health services.302  Singapore,
through these agencies and their regulatory policies, aspires to realize
“high standards of public health and a quality environment” for all
citizens.303  Singapore’s aspirations are evidenced in its multi-sectoral
regulation, including that governing its blood policies.304
The Singapore Blood Transfusion Service (SBTS) was founded
in 1946, prior to Singapore’s independence, and has since supplied
blood to all of Singapore’s private and public hospitals.305  The Singa-
pore Blood Transfusion Service, now the Center for Transfusion
Medicine (CTM), is controlled by the Ministry of Health.  Singapor-
ean blood policy protocols are regulated by the government under the
Infectious Diseases Act of 1976, and the Infectious Diseases
(Amendment) Act of 1992.306  HIV was first identified and confirmed
in Singapore in 1985;307 the first case of AIDS was reported in 1986.308
299. Li-ann, supra note 1, at 79.
300. Id.
301. Id. at 79 n.72.
302. The three Ministries overseeing health services in Singapore are the Ministry of Health
(MOH), Ministry of the Environment (ENV), and Ministry of Manpower (MOM).  Ministry of
Health Singapore, Overview of the Singapore Healthcare System 2 (2001), available at http://
www.gov.sg/moh/mohinfo/mohinfo_a.html (last visited Oct. 28, 2001).
303. Ministry of the Environment, The Singapore Green Plan—Towards a Model Green
City 8 (1992) (Sing.), quoted in Tookey, supra note 296, at 172.
304. See supra note 302.
305. Ministry of Health, Overview of the Singapore Blood Transfusion Service, available at
http://www.gov.sg/moh/health/sbts/sbt2.html (last visited Oct. 8, 2001).
306. CLB & Anor v. Public Prosecutor, 1993-1 SLR 589, 1993 SLR Lexis 434 (High Court,
1993) (Sing.); see also I. C. Boudville & S. Y. Wong, Health Care Systems In Transition II.  Sin-
gapore, Part II.  The Current Status of HIV-AIDS, 20 J. PUB. HEALTH MED. 23, 27 (1998).
307. FEDERAL RESEARCH DIVISION, LIBRARY OF CONGRESS, SINGAPORE: A COUNTRY
STUDY 112 (Barbara Leitch LePoer ed., 2d ed. 1991) [hereinafter SINGAPORE: A COUNTRY
STUDY]; see also Boudville & Wong, supra note 306, at 23.
308. Boudville & Wong, supra note 306, at 23.
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By 1988, thirty-four cases of AIDS had been diagnosed.309  The inci-
dence of HIV increased over the next decade; by the end of 1999,
2,600 adults, or 0.13% of the adult population of Singapore, were in-
fected with HIV.310  The “predominant mode” of HIV transmission in
Singapore has been sexual contact, which was “responsible for 95%
of the cases up to 1996.”311  Sixty-eight percent (68%) of HIV infec-
tions caused by sexual contact through 1996 resulted from heterosex-
ual contact, and 25.2% resulted from homosexual contact.312  As of
December 1999, 57.8% of HIV-positive Singaporean men had been
infected through heterosexual contact, compared to 27.1% infected
through bisexual or homosexual contact.313  Of the remaining HIV in-
fections diagnosed as of December 1999, 1% were caused by perina-
tal transmission, while 1.6% resulted from injection drug use.314
After the diagnosis of HIV in two Singaporeans in 1985, the gov-
ernment immediately implemented legislation and adopted measures
to prevent further spread of the disease.315  The legislation mandated
that SBTS screen all blood donations for antibodies to HIV.316  Two
years later, in 1987, the government enacted legislation requiring that
all prospective donors complete a “compulsory questionnaire-cum-
declaration” prior to donating blood.317  Since the implementation of
these screening procedures, no incidences of transfusion-transmitted
HIV have been reported in Singapore.318
309. SINGAPORE: A COUNTRY STUDY, supra note 307, at 112.
310. JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS & WORLD HEALTH
ORGANIZATION, EPIDEMIOLOGICAL FACT SHEET ON HIV/AIDS AND SEXUALLY
TRANSMITTED INFECTIONS, 2000 UPDATE, SINGAPORE, at 3 (2000), available at http://www.
unaids.org/hivaidsinfo/statistics/june00/fact_sheets/pdfs/singapore.pdf (last visited Oct. 10, 2001)
[hereinafter Singapore Fact Sheet].
311. Boudville & Wong, supra note 306, at 24.
312. Singapore Fact Sheet, supra note 310, at 6.
313. Id.
314. Id.
315. See The Infectious Diseases Act (Amendment of First Schedule) Notification 1985 No.
S 98 (Apr. 17, 1985) (Sing.); see also The Infectious Diseases Act (Prescribed Form) Regulations
1985 No. S 354 (Dec. 23, 1985) (Sing.) (providing the form to be used to notify the government
of incidences of infectious diseases including AIDS).
316. SINGAPORE: A COUNTRY STUDY, supra note 307, at 112.  The questionnaire used in
1985 could not be obtained.  This section will discuss the questionnaire currently in use.
317. Boudville & Wong, supra note 306, at 25.
318. Boudville & Wong, supra note 306, at 24 (“One case of infection occurred because of a
contaminated blood transfusion received in the early 1980s while the individual was in the
United States, whereas no cases have been attributable to transfusion of blood products in Sin-
gapore.”).  Though HIV-positive individuals have donated blood in Singapore, and been prose-
cuted accordingly, HIV was detected in their blood by serological screening.  Thus their blood
was not introduced into the blood supply.  See infra notes 319, 321.
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In 1992, the Infectious Diseases Act was amended to create
criminal offenses related to HIV/AIDS transmission.  These include
the offense created by Section 11(1): any false statement by a pro-
spective blood donor in response to the pre-donation questionnaire
can be prosecuted as a criminal offense.319  A violation of Section
11(1) carries “a penalty, upon conviction, of imprisonment of up to
two years or a fine of up to $20,000 or both for making a false declara-
tion.”320  Since 1992, there have been several prosecutions of individu-
als who provided false information in blood donor registration forms,
under Section 11(1) as well as under §182 of the Penal Code, which
proscribes giving false information to a public servant.321  Two indi-
viduals, who were HIV-positive at the time of donation, were charged
under Section 182, with “giving false information to a public servant,
the Medical Director of the Singapore Blood Transfusion Service.”322
Both were sentenced to “a week’s imprisonment and a fine of
$800.”323  Another person who donated blood on June 25, 2000 and
whose blood tested positive for HIV has been charged under Section
11(1).324  According to Singaporean epidemiologists, the use of pre-
donation questionnaires, to which one must respond honestly or face
threat of prosecution, deters individuals at risk of HIV from donating
blood to ascertain HIV status, and thus further contributes to a safe
blood supply.325
The Singapore Blood Donation Questionnaire, also known as
the blood donor registration form, prohibits individuals from donat-
ing blood for various reasons including low body weight, history of
major illness, or travel to high endemic regions.326  The questionnaire
also prohibits donation by any potential donor who may be at risk of
having a disease transmissible by blood.  A potential donor is ex-
cluded if he or she is in any of the following groups:
1) Persons with positive HIV test results or those with AIDS;
319. Press Release, Ministry of Health, HIV-Infected Blood Donor (Apr. 10, 2001), avail-
able at http://www.gov.sg/moh/releases/2001/10%20Apr%202001.html (last visited Oct. 28,
2001).
320. Id.; see also Boudville & Wong, supra note 306, at 25.
321. CLB & Anor v. Public Prosecutor, 1993-1 SLR 589, 1993 SLR Lexis 434, at *4 (High
Court, 1993) (Sing.); see also Press Release, Ministry of Health, supra note 319.
322. CLB & Anor v. Public Prosecutor 1993-1 SLR 589, 1993 SLR Lexis 434, at *4.
323. Id.
324. Press Release, Ministry of Health, supra note 319.
325. Boudville & Wong, supra note 306, at 25.
326. Singapore National Blood Donation Recruitment Programme Information, available at
http://www.redcross.org.sg/serv_bloodonorecruitprogm_Info.htm (last visited Oct. 9, 2001).
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2) Persons who have had multiple sex partners;
3) Persons who have engaged in casual sex;
4) Men who have had sex with other men;
5) Persons who have injected themselves with drugs;
6) Sex prostitutes;
7) Persons with symptoms suggestive of AIDS e.g. weight loss,
swollen glands in the neck, armpits or groins, persistent diar-
rhoea or rare cancers;
8) Anyone have had [sic] sex with anyone in these groups.327
Although homosexual or bisexual contact is responsible for only
27.1% of the HIV infections affecting men in Singapore, SBTS pro-
hibits blood donations by men who have had sex with another man.328
Similarly, although injection drug use is responsible for only 1.6% of
HIV infections in Singapore,329 individuals who have injected drugs
are prohibited from donating blood because the risk of such individu-
als donating seropositive blood is considered too high to be accept-
able.330
Because HIV is transmitted predominately through heterosexual
contact in Singapore, the questionnaire was constructed to deter indi-
viduals so infected from donating blood.  In Singapore, as of 1996,
67% of HIV-positive individuals were single, 25% were married, and
8% widowed or divorced.331  The “single most important risk factor
for HIV infection in Singapore” is “contact with commercial sex
workers during travel to other countries.”332  Questions two, three,
and eight effectively target individuals at risk from these transmission
mechanisms, by excluding men and women from donation who have
had sex with multiple partners or who have had sex with anyone who
might be at risk of HIV infection, including commercial sex-
workers.333
327. Id.
328. Singapore Fact Sheet, supra note 310, at 6.
329. Id.
330. The current seroprevalence of HIV in Singaporean populations of injection drug users
and homosexual men has not been estimated.  This information could be useful to determine
whether the exclusionary criteria functions to exclude a population that poses a significant risk
of introducing HIV into the blood supply, or whether the risk of introduction is minimal but still
present.
331. Boudville & Wong, supra note 306, at 23.
332. Id. at 24.
333. Singapore Blood Donation Questionnaire, supra note 328, at 6.
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The exclusionary criteria of Singapore’s Blood Donation Ques-
tionnaire are extensive.  Because the government privileges public
health and welfare over individual rights, and donating blood is not
considered such a right, neither the exclusionary criteria nor the at-
tendant criminal penalties have been challenged.  The combined use
of pre-donation self-exclusion questionnaires and serological screen-
ing as well as legal enforcement have proven effective in maintaining
the safety of the Singaporean blood supply: no incidence of transfu-
sion-transmitted HIV infection have occurred since their implementa-
tion.
IV.  CASE-STUDY SYNTHESIS/CONCLUSION
The above case studies present the legislative and public health
policy concerns and actions that contributed to the formation of co-
herent blood donation policies in the countries studied: the United
States, Canada, Denmark, Australia, Uganda, and Singapore.  The
overriding concerns of these countries in creating blood donation
policies are protecting the safety of the blood supply and preventing
further incidence of transfusion-transmitted HIV.334
All of the above countries, when forming their blood donation
policies, considered which populations were at risk for developing
HIV or had high seroprevalence.  Countries thus sought to create
policies that conformed to the available epidemiological information
on patterns of HIV transmission and infection.  In addition to formu-
lating and implementing effective blood donation policies, the impact
on individual interests and rights were also considered.  These coun-
tries sought to balance public health protection and the governmental
interest in creating blood donation policies that would prevent trans-
fusion-related transmission of HIV with minimal infringement on in-
dividual rights.  Furthermore, the questions asked in the pre-donation
exclusion questionnaires were formulated so as to exclude those indi-
viduals and groups at high risk of HIV infection.
The initial diagnoses of AIDS in the four Pattern One countries
discussed—the United States, Canada, Denmark, and Australia—oc-
334. Statistical information concerning the effectiveness of pre-donation donor self-
exclusion questionnaires in combination with serological screening to prevent transfusion-
related HIV infection is not available for all of the case-studies countries.  The data from those
countries for which this information is available suggests that this combination of measures has
been successful.  In the United States, the residual risk of transfusion-transmitted HIV infection
is 20 per million.  See supra note 43.  In Australia, this risk is significantly lower, at 7.9 per mil-
lion.  See supra note 242.  In Canada and Denmark, the risk is also quite low; however, data is
not available.  In Singapore, no incidences of transfusion-transmission HIV have been reported.
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curred in these countries’ homosexual populations.  Early diagnoses
of AIDS were also found in populations of Haitian immigrants and
injection-drug users.  Soon after the diagnoses of AIDS in these
populations, AIDS began to occur in the hemophiliac populations,
signaling not only that was AIDS transmissible by a blood borne
agent, but also that this agent was in the respective nation’s blood
supplies and blood products.  These countries were called upon to
implement policies to prevent further transmission of the disease.  At
least in the United States, Canada, Denmark, and Australia, these
early policies, which excluded MSM from donating blood because of
the high seroprevalence in homosexual populations, pitted gay rights
activists against public health policy makers.  All of these countries
eventually placed public health goals over individual civil rights con-
cerns.335  This reflected the policy position that public health measures
that effectively reduce the risk of disease transmission are justifiable
if they reduce the risk even minimally, so long as they do not unduly
restrict individual liberties.  Despite the conflicts over exclusionary
criteria, the policies implemented in the four countries were effective
in reducing transfusion-related transmission to today’s current low
levels.
The requirement of proportionality evidenced by the four Pat-
tern One countries’ approaches to drafting public health policy, dem-
onstrates the complexity of balancing public health priorities with in-
dividual rights.  It also highlights tensions between science and public
health, and law.  The former, especially as illustrated by the discipline
of epidemiology, considers groups over individuals, whereas the lat-
ter, at least as evidenced in representative and social democracies, is
concerned with balancing the interests of stable governance with in-
dividual rights.
The spread of HIV/AIDS has been held by these four countries
to be a sufficiently grave threat to citizens’ health to justify the pre-
ventive measures implemented.  Some of the measures adopted have
been more restrictive than others.  For example, Australian legisla-
tion making “false or misleading declarations by blood donors an of-
fense punishable by fine or imprisonment”336 closely resembles legisla-
tion enacted in Singapore, a Pattern Two country that explicitly
335. None of these countries recognize an affirmative right to donate blood; thus none con-
sidered prohibitions on blood donations by high risk groups to compromise individual liberty
interests.
336. Supra note 216.
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defines public health as a governmental interest for which individual
rights may be abrogated.
Conflict over balancing public health policies with individual
rights was not as evident in either Uganda or Singapore, the two Pat-
tern Two countries presented as case studies.  In Uganda, this is be-
cause the blood donation questionnaire does not explicitly prohibit
MSM from donating blood.  In fact, its exclusionary criteria are far
more general than those of any other country studied, only excluding
individuals from donating blood who are “unsure” about their part-
ners.337  In Singapore, this question did not explicitly arise because the
Singaporean Constitution provides that individual “liberties are sub-
ject to derogating laws relating to such collective interests as ‘public
order, public health, or morality.”338  The Singaporean Constitution
thus privileges public health protection, facilitating the easy drafting
and implementation of such policies.
In all of these countries, the blood donation policies adopted
combine the use of pre-donation and serological screening to reduce
the risk of transfusion-transmitted HIV infection.  All of the ques-
tionnaires exclude individuals considered to be at high risk for HIV
infection, although some questionnaires, such as those used in Singa-
pore, the United States, Canada, and Australia, are more tailored
than are others, for example that used in Uganda.  The question-
naires, however, screen out those groups with a high seroprevalence
of HIV infection, as well as individuals with high risk behaviors.
Public health policy formation and enactment is never simple,
especially when it concerns the development of blood policies to pro-
tect against transfusion-related transmission of a virus such as HIV.
The case studies presented in this note illustrate successful models for
drafting and enacting public health policies that ultimately achieved
the goals to which they were intended—reduction in the incidence of
transfusion-transmitted HIV without unduly compromising individual
rights or interests.
Francine A. Hochberg
337. See Reunión De Consenso Sobre Selección De Donantes En Bancos De Sangre [Con-
sensus Meeting Regarding the Selection of Blood Donors in Blood Banks] (Aug. 4, 1999) (Uru.)
(on file with the Duke Journal of Comparative and International Law).
338. Li-ann, supra note 1, at 110–11 n.72.
